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Abstract 
We present a new experimental-computational technology of inferring 
network models that predict the response of cells to perturbations and that 
may be useful in the design of combinatorial therapy against cancer. The 
experiments are systematic series of perturbations of cancer cell lines by 
targeted drugs, singly or in combination. The response to perturbation is 
measured in terms of levels of proteins and phospho-proteins and of cellular 
phenotype such as viability. Computational network models are derived de 
novo, i.e., without prior knowledge of signaling pathways, and are based on 
simple non-linear differential equations. The prohibitively large solution 
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space of all possible network models is explored efficiently using a 
probabilistic algorithm, belief propagation, which is three orders of 
magnitude more efficient than Monte Carlo methods. Explicit executable 
models are derived for a set of perturbation experiments in Skmel-133 
melanoma cell lines, which are resistant to the therapeutically important 
inhibition of Raf kinase. The resulting network models reproduce and extend 
known pathway biology. They can be applied to discover new molecular 
interactions and to predict the effect of novel drug perturbations, one of 
which is verified experimentally. The technology is suitable for application 
to larger systems in diverse areas of molecular biology. 
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Author Summary  
Drugs that target specific behaviors of signaling proteins are a promising new strategy for 
treating cancer.  One of the many obstacles facing optimal drug design is the incomplete 
understanding of the coordinated interactions between the signaling proteins at a 
quantitatively predictive level.  De Novo model inference refers to the algorithmic 
construction of mathematical models from experimental data without dependence on 
prior knowledge, in an effort to model these signaling pathways in a specific genetic 
context.  De Novo inference is difficult because of the prohibitively large number of 
possible arrangements of interactions.  Our lab has adapted a method called Belief 
Propagation that calculates probabilistically the most likely interactions, from which we 
can explore a large number of highly probable models.  In this paper, we test this method 
on artificial data and then apply it to model signaling pathways in a BRAF-mutant 
melanoma cancer cell line.  Our results show agreement with known biology, predict 
novel interactions, and predict efficacious drug targets, specific to the experimental cell 
line.  We believe that this methodology has the potential, with sufficient data, to model 
upwards of 100 proteins, a scale so far unreachable with current technology. 
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Introduction 
Signaling in cancer cells. Abnormal bio-molecular information flow as a result of 
genetic or epigenetic alterations may lead to tumorigenic transformation and malignancy 
and is classically modeled as changes in signaling pathways [1]. Targeted anti-cancer 
drugs, which bind and inhibit specific components of aberrant signaling pathways, are a 
promising alternative to conventional chemotherapy, with recent successes in melanoma 
(RAF inhibitor) [2] and prostate cancer (AR inhibitor) [3,4] following in the footsteps of 
the pioneering bcr/abl inhibitor Imatinib [5] and EGFR inhibitors Gefitinib and Erlotinib 
[6,7,8]. Combinations of targeted anticancer drugs hold considerable promise because of 
emergence of resistance to initially successful single agents and the highly robust nature 
of the signaling pathways with multiple feedback mechanisms [9]. 
 
Data-driven models of cell biology. High throughput measurements on response profiles 
of living cells to multiple perturbations such as drug combinations provide a rich set of 
information to construct quantitative cell biology models. In this paper, we construct 
context specific de novo mathematical models of signaling pathways through use of 
systematic paired perturbation experiments and network inference algorithms. Such 
network models will serve to gain insight into mechanistic details of signaling pathways, 
predict the response of cellular systems to multiple perturbations beyond the conditions in 
which models are generated and will be useful for design of perturbations that achieve a 
desired response. 
 
State of the art in network inference in cell biology. Previous mathematical models of 
molecular signaling in cells have been effective in modeling pathways and enhancing 
drug discovery [10,11,12,13,14,15,16,17,18,19].  Techniques for network modeling of 
signaling pathways span a spectrum of approaches at different levels of complexity. 
Modeling techniques in terms of detailed chemical kinetics and spatiotemporal models 
[17,20,21] can provide mechanistic explanations of observed behavior, but are often 
incompletely parameterized, needing tens or hundreds of kinetic parameters for medium-
sized systems. Moreover, such models may not be valid in biological contexts that differ 
substantially from dilute solution chemistry.  On the other end of the spectrum, pattern 
matching or machine learning models such as neural networks and correlation-based 
models such as maximum entropy [22] can accurately provide purely data-driven models 
of signaling. However, such methods have limited power to explain mechanistic details 
and, in most cases, are insufficient for quantitative predictions of system behavior in 
conditions beyond those from which the models are derived. 
 
 Data-driven and context-specific predictive models. Here, we take a unique modeling 
approach to construct context specific, de novo and predictive network models of 
signaling pathways from drug perturbation data (Figure 1). Here, de novo means that 
network inference is done without depending on known molecular interactions, e.g., 
extracted from literature or pathway databases that are not curated to account for 
biological context. This approach also emphasizes context specificity since it relies on 
rich experimental data from a single biological context as its training set. The models are 
constructed through parameterization of a simple model equation, which has been used in 
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other network modeling approaches [13,23,24,25,26,27]. The ansatz of the model 
equation yields parameters that are both mechanistically descriptive of system 
interactions (Supplemental Figure S15) and computationally predictive of cell-type 
specific response to new drug perturbations and perturbation combinations. We expect 
that the union of these advantages, will empower the community to identify unique drug 
targets and combinations that are particularly efficacious to the given context. 
 
 
Figure 1: Perturbation cell biology.  Perturbing cancer cells with targeted drugs singly and in pairs (A) 
reveals context-specific response to therapies and illuminates protein interactions.  We construct dynamic 
mathematical models of the cells’ response to drugs that have both quantitative parameters (B) and a 
qualitative network interpretation (C).  We use an inference algorithm called Belief Propagation (BP) to 
construct a set of good, i.e., predictive models (D). 
 
 
Network modeling de novo or with prior information. De novo construction of 
signaling network models at scales relevant to problems related to complex biological 
phenomena such as cancer has long been a challenge in system biology.  Thus, 
quantitative models of protein signaling pathways are typically constructed on the basis 
of existing prior knowledge from literature searches [16,17] and interaction databases 
[19,28,29].  However, different cancer contexts have unique genetic and proteomic 
alterations to normal protein signaling. Moreover, signaling pathways have a highly non-
linear nature with negative feedback loops, non-overlapping pathways and cross-talk etc. 
For example, distinct mutations in effector proteins of the PI3K pathway confer 
oncogenicity in unique ways leading to highly context dependent functional 
consequences across different cancer types, subtypes and patients [30]. The method we 
introduce in this document is capable of inferring parameterized network models with or 
without prior knowledge. We test our method without prior knowledge. An advantage of 
de novo inference is the liberation from prior knowledge interactions that may be 
incorrect in a given biological context.  
 
Model inference from perturbation data for larger systems is hard. The largest 
obstacle to de novo model construction is the combinatorial explosion in the number of 
possible networks [31].  Model inference problems of this type are NP-hard [32].  The 
number of possible configurations for a model with N nodes, and K possible values for 
each parameter grows super-exponentially as KNxN. We have previously described a 
method for de novo construction of dynamic nonlinear network models from perturbation 
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data [33]. This network construction method is based on the combined use of a Monte 
Carlo stochastic search algorithm, that is used to find the network topology and an 
efficient gradient descent algorithm [34] for quantitative parameter determination. 
However, without algorithmic improvements, such Monte Carlo based methods are 
limited to modeling fewer than approximately 15-20 biological entities [33]. Increasing 
the scale of network (or pathway) models of cellular signaling processes to levels 
sufficient to describe complex biological problems in quantitative detail is therefore 
extremely challenging and has been approach with a diversity of methods [35]. 
 
A statistical physics approach can handle the complexity for larger systems.  An 
ingenious, two-step approach to deal with larger systems is based on first calculating 
probability distributions for each possible interaction in the model and then computing 
distinct solutions by sampling these probability distributions. For this purpose, we 
devised a probability model of network configurations inspired from statistical physics 
principles. Using a set of approximations to simplify the probability model, we adapted 
an iterative algorithm called belief propagation (BP) that involves local optimization 
updates of inferred model parameters to eventually reach a globally optimized network 
model solution [36,37,38]. BP has been applied to various complex inference problems, 
some of them NP-Hard such as K-SAT [38] and graph coloring [39]. BP has garnered 
some attention in biological network inference [40,41] and parameter estimation [42] . 
Here, we have tailored the BP algorithm to large-scale perturbation data that is capable of 
increasing the scope of the models to hundreds of nodes.  The result of belief propagation 
is a set of probability distributions for each model parameter, often referred to as 
marginals. Each marginal describes the inferred distribution of a particular parameter 
across a range of ‘good’ solutions. Individual models are created via the belief 
propagation guided decimation algorithm [43]. Consequently, the time-complexity of the 
problem is strongly reduced, the prohibitive computational demands of combinatorial 
complexity are circumvented and, although the method provides only an approximate 
solution, one obtains useful, non-trivial results.  
 
In practice: from systematic perturbation to response profiling to network model 
inference. Our algorithmic network pharmacology approach involves four major steps: 
(i) perturbation experiments with combinations of targeted compounds, (ii) high-
throughput proteomic measurements, e.g., with reverse phase protein array (RPPA) 
technology or mass spectrometry, and quantitative measurements of phenotypic features 
such as cell viability, (iii) inference of quantitative network models of signaling that link 
changes in proteomic profiles to changes in phenotypic profiles in response to single or 
multiple perturbations in specific biological contexts, and (iv) use of the network models 
to predict  cellular and molecular responses to diverse perturbations, beyond the 
conditions on which the network models are derived. 
 
Experimental and computational technology for network model inference and 
application to drug effects on melanoma cell lines. Here, we have adapted a 
probabilistic inference strategy to construct quantitative network models of signaling 
pathways from systematic perturbation experiments. First, we evaluated the speed and 
accuracy of BP on biologically inspired toy models. The inference of toy models, which 
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mimic biological pathways, reveals that BP offers a significant improvement in 
computational efficiency compared to traditional Monte Carlo simulations without a 
sacrifice in accuracy. Next, we have constructed network models of signaling in a RAF 
inhibitor resistant melanoma cell line (SKMEL-133), which has the BRAFV600E 
mutation [44]. Finally, we have successfully predicted the proteomic and phenotypic 
response profiles of melanoma cells to multiple combinations of targeted drugs using 
numerical simulations with in silico perturbations. With the introduction of many novel 
targeted drugs and patient specific genomic profiling, the described network 
pharmacology approach aims provide an effective tool to develop individualized, 
combinatorial therapeutic approaches against multiple cancer forms. 
 
RESULTS  
Theory 
Mathematical	  form	  of	  the	  network	  model	  
A key decision in modeling a biological cellular system is the choice of variables and the 
mathematical framework for representing system dynamics. Here, we work with a fairly 
simple but powerful ansatz or framework, in which the time behavior of the cellular 
system { xi (t) } in a set of perturbation conditions {ui µ} is modeled as a series of coupled 
non-linear differential equations (Equation 1) [33].  
 
Equation 1: Non-linear network model for the time behavior of the cellular system 
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 Here, {xi(t)} denotes the set of temporal trajectories for all xi, i  is an index over the 
network nodes, and µ  is an index over the different perturbation conditions. 
Perturbations consist of targeted drugs applied alone or in pairs, each of which inhibits 
the kinase activity or function of specific proteins. In most cases the kinase activity is not 
directly measureable, and thus kinase inhibitors are incorporated into the model as so-
called activity nodes, which couple the force of external perturbation throughout the 
whole system (See Methods section). 
 
Each network node is modeled as a variable corresponding to a real number value.  This 
value quantifies the relative concentrations of biological molecules (proteins, phospho-
proteins or RNA molecules) or phenotypic attributes such as growth. In this framework 
the value of xiµ is the log2 ratio of the quantity of the ith entity in perturbation condition 
µ  relative to the unperturbed condition. Consequently, model variables can take both 
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negative and positive values denoting decreased or increased quantities of the 
corresponding biological entity. In the absence of absolute concentrations, we chose to 
normalize protein measurements against unperturbed levels so as to focus on signaling 
differences due directly to perturbation. 
 
 
The rate of change for any variable is predominantly driven by the additive linear 
combination of upstream nodes { x j } weighted by their respective parameters {wij }. 
Non-zero values of wij denote interactions in the network model.  We incorporate 
nonlinearity with a sigmoidal function φ(z)  that limits both the maximum positive and 
negative rate of change [24]. The αi  parameter models the rate of restoration at which a 
model variable would return to its initial value before perturbation, absent interactions. 
This is analogous to the degradation rate in models of positively valued protein 
concentrations. The 
  
εi parameter tunes the saturation levels for each model variable.  The 
parameters εi  and αi  are not inferred with BP, and thus to reduce the mathematical 
notation are assumed to be 1 for the remainder of this section. 
 
After perturbation from some initial state at t=t0, the system variables xiµ (t)  in each 
condition  evolve in time and, in general, reach a steady state at time t=ts. The 
variables ui model the external influence of a perturbing agent (such as a drug) on model 
node xi. In principle, ui is time-dependent, but not in the current implementation.  A 
perturbing agent acting on a set of target nodes {xi} is represented as a vector with non-
zero values for {ui}.  Similarly, a combination of drugs is modeled as the simple sum of 
such perturbation vectors.  
 
The network models are parameterized by the interaction matrix W = {wij}, where wij  
represents a directed interaction between nodes, quantifying the influence of xj on the rate 
of change of xi.  In chemical kinetics, the wij is analogous to rate constants in units of 
inverse time, although no explicit rates are derived here. Equation 1 describes the 
dynamic behavior of the system, given a constant interaction matrix W. These apparently 
simple models can represent biologically realistic regulatory motifs, such as serial and 
parallel pathway connectivity, positive and negative feedback loops and feed-forward 
control.  
 
Our models are dynamic in the sense that they produce simulated trajectories that settle at 
a final steady state. However, in this work, the parameters are inferred based solely on 
steady state data. Consequently, the trajectories of the model simulations are 
unconstrained to experimental measurements. 
 
The	  problem	  of	  model	  inference	  
The problem of deducing useful models of a (biological) system is called 'model 
inference'.  The objective of model inference, given a mathematical framework like that 
described above, is to find a set of parameters such that the model equations best 
€ 
µ
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reproduce a training set of experimental data and have predictive power beyond the 
training set. In the present modeling framework, we aim to find numerical values for the 
N2 parameters in the interaction matrix W, such that descriptive and predictive power of 
the model is optimized. Genuine predictive power, rather than just descriptive power, 
requires both low error and low complexity of the model, combined as low cost. More 
precisely, we quantify the cost of W by an objective cost function C(W) that penalizes (a) 
discrepancies between predicted ( xi
µ ) and experimental ( xiµ* ) values  of the system 
observables at a set of time points {tl} in condition µ, and (b) the number of non-zero 
interactions in W. Lower cost models tend to have better predictive power than higher 
cost models.  
 
Equation 2: Model configuration cost function 
C(W) = β xi
µ (tl )− xi
µ*(tl )( )2 + λ δ (wij )
j≠i
N
∑
i
N
∑
µ
M
∑
i
N
∑
l
L
∑                    2.a
δ (wij ) =1 if wij ≠ 0                                                                   2.b
δ (wij ) = 0 if wij = 0
 
 
C(W) is thus the error-plus-complexity cost of a parameter configuration W.  The cost 
components are weighted by β  and λ , respectively.  The complexity cost term is an L0 
penalty [45,46,47,48,49] that penalizes non-zero entries in W and is included to both 
avoid over-fitting and reflect the empirical observation that realistic biological network 
models such as gene regulatory networks or protein-protein interaction networks are 
sparse [50], and although L1 penalties are convex and therefore amenable to efficient 
convex optimization methods, they are often a weaker constraint on the complexity of the 
interaction matrix W [25,51,52,53].  We do not wish to include direct self-interaction in 
the present version thus the sum in the complexity term does not include the diagonal 
elements wii . The computational challenge of network inference is to translate the 
information contained in a set of experimental observations into an optimal set of models, 
as represented by a set of low cost interaction matrices W.  In this report, as we work in 
the steady state approximation, we ignore the time variable in the cost function in 
equation 2, and only consider steady state solutions of equation 1 based on two data 
points at t=t0 and t=ts. 
De	  novo	  network	  inference	  is	  a	  hard	  problem	  	  
In principle, to infer optimal network configurations one has to compute the cost of all 
possible network configurations. However, explicit enumeration and cost calculation of 
all possible parameter configurations W is a prohibitively complicated task for even 
moderate size systems.  To estimate the complexity of this task, assume that any wij can 
take on K discrete values out of a value range Ω, for example, Ω={-1,0,+1} for K=3, 
representing inhibition, no interaction and activation, respectively.  As the number of 
model nodes N increases, the number of possible parameter assignments increases as 
KN 2 . Even for moderate N, e.g., 20 nodes, the number of distinct solutions is of order 
10190, obviously a very large number, making explicit enumeration prohibitive.  
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A reasonably clever strategy to traverse this enormous solution space is guided random 
exploration, e.g., by a traditional Monte Carlo search, in which random moves in multi-
dimensional parameter space are kept or rejected based on the cost of the resulting 
configuration, with a non-zero but small probability of accepting higher cost solutions in 
order to facilitate the escape from local minima. In an earlier implementation of the 
network model of equation 1, we successfully used a Monte Carlo search followed by a 
modified gradient descent method to generate a set of low cost solutions for a relatively 
small system. This earlier algorithm achieved a reasonable exploration of solution space 
for a system of 14 nodes, as assessed by the recurrence of dominant interactions across a 
set of a few hundred low-cost solutions and the agreement of those interactions with well-
established knowledge of signaling pathways in cell biology. However, the KN 2 argument 
above and explicit computational benchmarking indicate that such Monte Carlo searches 
become prohibitively expensive for larger systems. 
 
Fast	  inference	  via	  a	  probability	  model	  of	  network	  configurations	  
In search of a more efficient algorithm, we adopted an idea originally developed in 
statistical physics, and widely used in solving complicated optimization problems in 
computer science and other areas. Instead of blindly (or cleverly, using a Monte Carlo 
procedure) sampling an exponentially large solution space by traversing a set of 
individual solutions (parameter configurations), the idea is to infer system parameters 
from data in a probabilistic framework. In particular, one first calculates a probability 
distribution over value assignments for each parameter in the model, and then generates 
distinct model configurations by sampling from the calculated probability distributions, 
thus greatly reducing the effective size of the search space.  
 
The basic idea is that models with a large error (or cost) have low probability, while those 
with a low error (or cost) have high probability. More precisely, the probability of any 
particular model can be computed from its cost, which depends on its interaction matrix 
W and the experimental data (Equation 2).  In statistical physics, there in an analogous 
relationship between the Hamiltonian for the states of a system and its Boltzmann-Gibbs 
probability distribution over all states. In Bayesian inference, the below equation relates 
the posterior distribution of the model on the left to the likelihood function and prior 
distributions on the right. 
 
Equation 3: The probability model of network configurations 
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Here, Z is the partition function, which ensures that the sum of the probabilities over all 
models (all states of the system) is equal to one.  In the statistical physics analogy, the 
exponents contain interaction energies and the parameter β is an inverse temperature 
(1/T), such that higher values of 
  
β  assign higher probability to lower cost configurations.  
The parameter λ is the weight of the complexity penalty. The choice of 
  
β  and 
  
λ  is non-
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trivial and is an open area of research: see methods for more information on how these 
parameters are set for this study.  Given the probabilistic model in equation 3, the 
practical challenge is to identify parameter sets W that represent maximally probable 
('good') models, given the data. The explicit computation of probabilities for all possible 
sets of parameters is not feasible even for moderately sized (N>15) systems. One 
therefore has to invent practical algorithms for effectively exploring the total solution 
space and approximately determining sets of good models.   
 
Iterative optimization of the probability model 
 
An effective solution is to use an iterative algorithm to approximate the probability 
distributions of the individual parameters by themselves, often called marginal 
distributions, from which we can describe high probability, full model configurations.  
This iterative algorithm begins with a set of random probability distributions. In each 
iteration step, one assumes approximate knowledge of a set of probability distributions 
for all parameters ('global information’) and then performs optimization updates on 
individual model parameters ('local updates'). The local updates take effect and become 
part of the ‘global information’ for successive iterations, migrating over different 
individual parameters.  The iteration terminates when it reaches convergence to a stable 
set of probability distributions.  At each iteration step, the probability distribution for a 
local parameter (e.g., a node-node interaction parameter) is calculated based on fitness to 
experimental data and consistency with the global information about the other 
parameters. The iterative application of this 'global to local and back' optimization 
strategy results in probability distributions for all system parameters given a probabilistic 
model. Such optimal probability distributions are informative in themselves, but also can 
be used productively to construct a population of explicit individual low-cost parameter 
configurations, e.g., for explicit simulation of system behavior. 
 
This type of probabilistic method originates in statistical physics and was generalized to a 
number of hard optimization problems in statistical physics and computer science. An 
early application of such probabilistic inference was inverse parameter inference for 
disordered diluted spin systems [54,55,56]. A well known formulation in terms of 
Bayesian statistics led to the term 'belief propagation' [57].   
 
The belief propagation approach, also known as the Bethe-Peierls approximation or 
cavity method in statistical physics, provides an approximate method for computing 
marginal probability distributions on a class of probabilistic graphical models called 
factor graphs.  A joint probability distribution over many variables may factorize into a 
product of factors. A factor in a factor graph represents an independent contribution to 
the joint probability distribution, and is connected to the variables that depend on that 
factor.  The BP method is proven to be exact on tree-shaped factor graphs.  It has found 
many useful applications to approximate distributions on sparse factor-graphs [58,59] 
where the influence of loops in the factor graph is expected to be weak.  More recently, 
several applications to dense, loopy factor-graphs have been proposed [40,60,61,62,63].  
The problem we address here is a dense factor graph, where each factor is connected to N 
model parameters. (Figure 2) 
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A major advantage of belief propagation algorithms is the reduction of computational 
complexity. This not only leads to a substantial reduction in computational effort for 
smaller systems but also opens the door to solving inference problems for larger systems, 
which would otherwise be prohibitive.  
 
 
Figure 2: Iteration process for Belief Propagation. Top panel: the global information consists of 
collecting the probability distributions of the non-cavity parameters without the contribution from the 
cavity condition.  This is a simple product over all ρν (wij )  factors except that from the cavity constraint (
µ ).  Distributions centered on zero denote unlikely interactions (see j=2), centered on the right of zero 
denote likely positive interactions (see j=3), and centered on the left denote likely negative interactions (see 
j=N). These distributions inform the parameters of the Gaussian distribution for the mean-field, aggregate 
sum variable skµ .  The distribution Pµ (skµ )  summarizes the state of the non-cavity parameters.  Bottom 
panel: we calculate the probability of each possible parameter assignment (
€ 
ω ∈ Ω) to the cavity parameter 
(wik ) constrained to the data in the cavity condition.  This calculation boils down to a simple convolution 
of the fitness function with a fixed parameter assignment (
€ 
F µ (skµ )) with the probability of the aggregate 
sum variable Pµ (skµ ) , obtained by integrating over all values of skµ .  Each assignment ω ∈Ω  
contributes proportional to the area under the curve.  The resulting update is the contribution of condition 
µ  on the distribution of wik , denoted ρµ (wik ) .  This recently updated distribution becomes part of the 
global information for successive updates to other parameters. 
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Simplified	  probability	  model	  of	  network	  configurations	  
We use a series of assumptions, described below, to simplify equation 3 into a form that 
can be efficiently calculated without sacrificing the quantitative and predictive nature of 
the solutions. The assumptions introduced below reduce the problem from a probabilistic 
description over whole configurations into a collection of probabilistic descriptions for 
each individual parameter, or ‘marginals.’ Subsequent sampling from these individual 
marginal probabilities will result in efficient exploration of high probability model 
configurations. 
 
 
Assumption 1: Discrete set of real valued parameter assignments. To simplify the 
probability model, we compute the probability distributions for model parameters over 
discrete values, from a set Ω, rather than for continuous values. The choice of 
discretization is important and affects the convergence properties of the BP algorithm and 
the quality of the resulting probability distributions.  Empirically, with the data set at 
hand we find that 11 discrete values, centered at zero, rarely fails to converge to a stable 
set of marginal probabilities. Conversely, searching over only 3 weight values results in a 
high rate of non-convergence. As for the quality of the resulting distributions, the 
entropies of the marginal distributions are close to zero as we limit the search to only 3 
discrete values (see Supplemental Text S4). The entropy is a statistical measure of the 
uncertainty in the distributions, such that zero entropy distributions imply absolute 
certainty, where each parameter is predicted to be 100% zero or 100% non-zero. This is 
an undesirable quality since we want the BP marginal distributions to constrain a set of 
high probability solutions, not return one parameter set.  In practice, discretizing with 11 
weights gives intuitively reasonable distributions and a reasonable balance between 
exploring and constraining solution space. 
 
In the final stage of network inference strategy, we refine the set of discrete valued model 
parameters to solutions with continuous model parameters using a local gradient descent 
optimization algorithm [33]. 
 
Assumption 2: Decoupling of nodes at steady state.  In the dynamic model, the system 
variables  {x(t)i} are coupled such that a change to any variable propagates to all others 
via the time derivatives as in Equation 1. A rigorous way to compute the fitness of a 
configuration is to simulate a configuration and then compare simulation output to the 
training data. Such a computation, while feasible in principle, is very costly. An 
alternative solution is to take advantage of the relationship at the steady state (equation 4) 
where the time-derivative is equal to zero. 
 
Equation 4: Model equation at steady state 
 
xiµ = −φ wijx jµ +uiµ
j≠i
N
∑
$
%
&&
'
(
)) for all variables i and experiments µ  
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Equation 4 is a system of self-consistent equations for all nodes {xi}. To avoid having to 
do numerical simulation, we replace {xjµ} on the right hand side of Equation 4 with 
experimentally observed {xjµ*} at the expense of self-consistency (Equation 5).  
 
 
Equation 5: Approximate model equation at steady-state 
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This approximation has the feature that the model variables become uncoupled from each 
other: the model predicted value of xiµ  depends only on the parameters in the ith row of 
the interaction weight matrix W and on the set { xjµ*} of experimentally measured values 
in condition µ .  With this, the posterior probability P(W) can be factorized as a product 
of independent posterior probability distributions over value assignments to individual 
rows of the weight matrix. Consequently, we have an independent probability distribution 
for each row of the interaction weight matrix ( ). These rows describe the effect of the 
variables j ∈ {1…N}  on a single variable xi , according to Equation 5. The resulting 
factorized expressions are:  
 
Equation 6a-d: Probability model of configurations with decoupled nodes 
 
P(W ) = P(Wi
i
N
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We introduce the notation  to denote the fitness of the model configuration  to 
the data from experimental µ. It is important to note that the posterior probability 
distribution in Equation 6d factorizes over the fitness functions, such that  
contributes independently to the full probability distribution of that configuration. The 
probability distribution in 6d, however, does not factorize any further, since each 
parameter wik in Wi depends on the other parameters in Wi.  In order to reach good 
solutions for 6d without enumerating all configurations Wi, we apply an iterative method 
to infer probabilities for the constituent parameters {wij 
  
∀ j}, from which we can sample 
and enumerate high probability configurations Wi.   
€ 
Wi
€ 
F µ (Wi)
€ 
Wi
€ 
F µ (Wi)
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Belief	  propagation	  algorithm:	  iterative	  updates	  of	  probability	  estimates	  	  
As already mentioned above, the belief propagation method consists of randomly ordered 
updates to the probability distributions for individual parameters, one at time.  Updates 
continue until convergence, when the probability distributions do not change between 
consecutive updates. We describe the method in detail below for single Wi since the 
procedure is independent and identical for all rows i ∈ {1…N}  due to Assumption 2.  
The update procedure is schematically diagramed in Figure 2. 
 
Local updates with global information.   A local update takes place inside an abstract 
'cavity', which isolates a single parameter distribution to be updated (wik) and data from a 
single experimental condition (µ).  Each update maximizes the fitness to the experimental 
data in the cavity condition and compatibility with global information (i.e., probability 
distributions of other parameters), which evolves as the algorithm iterates. A local update 
is a change to the cavity parameter’s distribution constrained to fit the experimental data 
and global information. A single distribution is locally updated in one step and becomes 
part of the global information for updating other distributions in successive steps. This 
local update is repeated in all possible cavities (i.e. all combinations of parameters and 
conditions) until global convergence of the distributions is reached. 
 
Just as Equation 6d factorizes over different experimental conditions, so too do the 
probability distributions for any single parameter.  Recall that we are optimizing 
parameters in a single row of W so for the following equations the index i is fixed.  We 
define ρµ(wij) to be an independent factor that represents the probability distribution of a 
single parameter given data from experiment 
  
µ and compatibility with other parameters.  
The BP algorithm begins with randomly initialized distributions for all ρµ(wij). Therefore, 
the algorithm starts with random probability distributions for all parameters. The initial 
choice of cavity parameter (wik) and cavity condition (µ ) is random. The update of the 
local ρµ(wik) in a single cavity depends on global information, which is simply a set of 
approximate probability distributions for the non-cavity model parameters (Pµ (wij ), j ≠ k
).  The approximate probability distribution for each model parameter is calculated at 
each update as a product of factors (ρυ(wij)) from all experiments except the experimental 
condition (µ) in the cavity.  
 
Equation 7: Global information of non-cavity parameters 
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The exponent λδ(wij) is an independent penalty for non-zero parameter assignments, 
which encodes prior knowledge that most parameters are zero.  This helps prevent overly 
dense network configurations. The superscript µ in 
  
Pµ (wij ) denotes the exclusion of the 
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contribution from experimental condition µ. In the following step, the distribution ρµ(wik) 
is updated to fit the data in a single experiment µ in the context of global information. 
 
Calculating local update ρµ(wik).  We define Wi\k to be a configuration of the ith row of 
W where the parameter wik is fixed. The distribution ρµ(wik) reflects the fitness of the 
parameter with Wi\k weighted by the probability of observing the particular configuration 
(Wi\k) as in Equation 8. 
 
Equation 8:  Local update to probability distribution of cavity parameter 
 
ρµ (wik =ω ) = F
µ (Wi\k )P
µ (Wi\k )( )
Wi\k
∑  ∀ω ∈Ω       8.a  
F µ (Wi\k ) = e
−β xi
µ*−xi
µ( )2                                                   8.b  
 
In the field of optimization algorithms, these equations are sometimes referred to as 
messages as they communicate information between parameter nodes and factor nodes on 
the factor graph.  Thus, Belief Propagation belongs to a class of ‘message-passing’ 
algorithms.  It is common to see Equation 7 referred to as messages from the parameter 
nodes to the factor nodes and denoted Pj→µ (wij ) .  Similarly, Equation 8 can be thought of 
as a message update from the cavity factor node to the cavity parameter node, denoted 
ρµ→k (wik ) . 
 
Assumption 3:  Independent model parameter distributions. Equation 8 is the 
mathematical definition of the factor distribution ρµ(wik). However, a brute force 
approach for calculating ρµ(wik) as in Equation 8a is computationally prohibitive.  The 
first complication is that computation of the joint-probability distribution Pµ(Wi\k) is not 
possible if we consider the interdependencies of the non-cavity parameters. To 
circumvent this problem, we assume that in the context of the local update, each 
parameter probability distribution is independent.  Then the joint probability distribution 
can be calculated as the product of the individual parameter distributions. 
 
Equation 9: Approximation of the joint distribution for the cavity update 
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Therefore, Equation 8 becomes Equation 10. 
 
Equation 10: Local update with factorized probability distributions 
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This equation is equivalent to the sum-product formulation, which is standard in belief 
propagation algorithm literature [58]. It is important to note that the assumption that the 
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joint probability distribution is factorized as the product of individual distributions 
(Equation 9) is exact on tree-shaped factor graphs, but is only an approximation in 
general. This assumption does not extend beyond the context of the cavity update 
calculation.   
 
Assumption 4: Gaussian mean-field approximation. Another complication in Equation 
11 is that a brute force implementation of the sum operation requires enumeration over an 
exponentially large number of configurations, which in total is KN-1.  Specifically, we 
replace the sum over multi-variate configurations (Wi\k) with an integral over a single 
scalar variable ( skµ ). To achieve this, we replace the fitness function’s dependence on the 
multivariate configuration Wi\k with a single scalar variable skµ . This transformation is 
explicitly defined in Equation 11, where the new variable skµ  represents the aggregate 
contribution of the non-cavity parameters to the fitness.  
 
Equation 11: Aggregate effect of non-cavity parameters  
F µ (sk
µ ) = F µ (Wi\k ) = e
−β xi
µ*−φ (sk
µ+wikxk
µ* )( )2               11.a
sk
µ = wijx j
µ* + ui
µ
j≠k
N
∑                                            11.b
  
 
In addition to this change of variables in the fitness function, we also require a 
description of the probability of the new variable P(s
k
µ
) .  Note that the dependence of skµ  
on Wi\k is through a linear combination of the individual parameters, which by 
assumption 3 are independently distributed.  We invoke the central limit theorem to 
approximate P(s
k
µ
)  as a Gaussian [64]. The mean and variance of this Gaussian are 
described by the means and variances of the global distributions given by Pµ (wij )∀j ≠ k .  
Thus, we replace the sum over multivariate configurations with the Gaussian integration 
of skµ  (Equation 12). 
 
Equation 12:  Gaussian integration of local update to cavity parameter   
∫
∞
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≈= µµµµµµ ωρ kkkik dssPsFw )()()(  
 
The explicit calculation of Pµ (skµ )  is described in Equations 13a-d. 
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Equations 13a-d: Statistical description of mean-field parameters 
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Iteration of update equations. In summary, the following belief propagation equations 
are calculated for each cavity update iteratively until convergence.   
 
Equations 14a-b: Update equations 
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Calculation of parameter probability distributions. When the above iterative 
equations converge, the final distributions for each of the model parameters are 
calculated from the set of factors, reflecting the information from experimental 
constraints.  
 
Equation 15: Probability distribution of a single parameter. 
∏−=
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The	  belief	  propagation	  algorithm	  provides	  probability	  distributions	  of	  model	  parameters	  
characterizing	   a	   set	   of	   good	   models.	   Thus,	   we	   reduce	   the	   unbounded	   model	   search	  
space	   to	   a	   set	   of	   tractable	   probability	   distributions	   for	  model	   parameters.	   Next,	   one	  
must	   generate	   high	   probability	  models	   by	   drawing	   from	   the	  BP	   calculated	   probability	  
distributions.	  	  
Network	  model	  instantiation	  by	  'decimation'	  guided	  by	  belief	  propagation	  
The belief propagation (BP) algorithm generates a set of probability distributions for each 
model parameter. However, we need distinct model solutions to proceed with predictive 
and quantitative analysis of signaling pathways.  Distinct solutions are generated by the 
belief propagation guided decimation algorithm [43] from BP generated distributions for 
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each interaction. The decimation algorithm works as follows. (i) An initial BP is run to 
compute probability distributions P(Wij) for all possible interactions. (ii) A possible 
interaction (suppose an edge that connects node k and node l) and an associated edge 
value (wkl=ω ) is chosen. The edge is chosen based on a probabilistic draw among all 
possible edge values for all edges. The probability of choosing an edge value is 
proportional to its BP computed probability. (iii) The probability for the chosen edge 
value is fixed to P(Wkl=ω )=1. (iv) A second round of BP is run with fixed P(Wkl=ω )=1. 
(v) Steps i-iv are repeated until an edge value is fixed for all possible interactions in the 
system. This procedure generates thousands of network models with varying 
configurations and error profiles. The non-zero parameters in each model are further 
optimized using a gradient descent algorithm, which relaxes the discretization of 
parameter values and further lowers the error by fine-tuning the real number values of the 
parameters.  Moreover, the gradient descent refinement ensures that the network models 
are mathematically in steady state and the nodes in the network models are fully coupled 
[33]. Each model is then a set of differential equations describing the behavior of the 
system in response to perturbations. 
 
Direct vs. Indirect Interactions:  Due to limitations in experimental measurements, not 
all proteins and their many phosphorylated sates are directly measureable.  The result is 
that many key intermediate players are excluded from the model. For this reason, direct 
interactions in our model do not necessarily imply direct biological interactions  
(Supplemental Figure S15). Increasing the number and quality of protein and phospho-
protein measurements increases the chance of modeling direct interactions. 
 
Technical performance 
We developed an experimental-computational technology, in the spirit of systems 
biology, which integrates perturbation experiments and network inference algorithms to 
construct quantitative models of signaling pathways and predict responses to drug 
combinations in a collection of cells. We first tested our technology to infer network 
models of artificially generated data. With these technical tests, we demonstrated that we 
can infer network models with good accuracy and achieved major speed performance 
improvement over conventional Monte Carlo (MC) based methods.  Furthermore, the 
synthetic data is generated without the assumptions utilized in the formulation of BP, and 
therefore serves as a reasonable test of the sensitivity of the BP method to those 
assumptions. Next, we applied the technology to perturbation data in a RAF inhibitor 
resistant melanoma cell line (SKMEL-133). We demonstrated that the technology 
successfully captured already known interactions and predicted new ones in signaling 
pathways. We tested the quantitative descriptive power of the method by quantifying the 
ability to reproduce the response profiles from withheld experiments. We then used in 
silico simulations and to predict the effects of novel drug perturbations, particularly the 
inhibition of Polo-like Kinase 1 (PLK1). 
 
The success of BP depends on whether or not the simulations of the models taken from 
BP are quantitatively predictive of cellular response to drug combinations.  It is also 
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useful, however, to evaluate the overall performance of the BP algorithm on data sets 
engineered from completely known networks.  With such toy datasets we (i) 
demonstrated that BP converges quickly and correctly,  (ii) compared BP network models 
to the known data-generating network, and (iii) evaluate performance in biologically 
realistic conditions of noise and sparse perturbations.  See methods for more information 
on how the toy data is generated. 
 
Belief Propagation is fast and accurate.  MC is a strategy for sampling the space of 
explicit solutions, in which full parameter configurations are searched as a whole.  Short 
of infinite coverage, a thorough MC search yields reasonably accurate approximations of 
the true probability distributions; both posterior probability distributions of explicit 
configurations, and marginal probabilities of individual parameters, calculated by 
counting the frequency of any parameter assignment across the set of good solutions. MC 
is a ubiquitous optimization strategy in the statistical physics community, and its ubiquity 
makes it a valuable candidate for comparison. We examined speed and accuracy 
performance of MC and BP for increasingly large models.  To do this, one toy data 
generator was constructed for each of the ten different sizes from N=10 to N=100.  The 
number of training patterns equaled the number of nodes for consistency of comparison, 
i.e. M=N.  Both methods searched a very large parameter space of 41 possible parameter 
assignments with   
  
Ω = {−2,−1.9,…,1.9,2.0}; thus for this toy dataset the search space of 
all configurations was of order 41N.  
 
The first criterion of interest was time of convergence (Figure 3A). For both methods, the 
time required for convergence increases as the size of the system increased, but MC was 
consistently about three orders of magnitude slower than BP. The speed advantage of BP 
is vital for our ability to scale up the size of de novo model construction to hundreds of 
proteins, phospho-proteins and cellular phenotypes.  
 
The second criterion was accuracy. While we were interested primarily in the accuracy of 
predicting responses to new perturbations, we were also interested in the accuracy of the 
inferred interactions as an indicator of the models’ explanatory and predictive power. In 
practice, we found that BP did no worse than MC on these datasets given reasonable 
termination conditions for MC (Supplemental Text-S5). 
 
A Pearson correlation coefficient between the set of non-zero parameters in the data 
generators and the average values inferred by BP (blue) was a reasonable measure of 
agreement between true and inferred parameters.  BP resulted in a correlation of R=0.7, 
which was quite high considering the relatively small number of training patterns used 
for each inference (M=N). As the number and quality of training pattern increases, the 
correlation approached 1 (Supplemental Text S1, Supplemental Figures S2 and S3).  A 
more critical metric of accuracy was the agreement with the training data.  The average 
parameter strengths inferred from BP and MC were used to calculate the expected value 
of the data points (as in Equation 6D).  Both MC and BP reproduced the training data 
very well as quantified by mean squared error per data point (Figure 3C). For reference, 
both BP and MC errors were at least two orders of magnitude better than what was 
expected at random. 
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While other parameter search methods such as genetic algorithms [65], simulated 
annealing [66], regression  [52,67], lasso-regression [52], Hybrid Monte Carlo [68,69,70] 
and Kalman filtering  [71] may offer improvements in speed over the standard MC 
comparison used here, they also suffer from poor scaling properties in the absence of 
prior knowledge. A statistical-mechanics analysis demonstrated that BP outperforms 
mutual information based inference algorithms since BP takes into account the collective 
influence from multiple inputs [72]. We conclude that BP offered a tremendous speed 
advantage over MC at no observable loss of accuracy.  
 
BP reproduces true interactions. BP 
inference was fast and almost perfect 
when the system had been sufficiently 
explored by perturbations.  In the case 
of toy data, one can perturb any set of 
nodes simultaneously with complete 
control, and generate information-rich 
data sets. Use of rich data sets provided 
a sufficient training set for BP to 
produce near perfect inference of the 
underlying system (Supplemental 
Figure S2 and S3). In biological 
experimental conditions, however, we 
are limited by the availability, strength 
and specificity of the drugs, by the 
availability of reporters (such as 
antibodies) as well as the technical 
accuracy of the measurements.  We are 
further limited by the financial and 
temporal cost of testing all 
combinations, even for the drugs that 
are available.  
 
Here, we evaluated BP performance in 
biologically realistic conditions; small 
number of sparse perturbations applied 
individually and in pairs.  The 
inference is repeated with added noise 
to evaluate sensitivity to noise.  The 
Gene Network Generator GeNGe [73] 
constructed the structure of positive 
and negative interactions for the data 
generator. The data generator network 
contained several common regulatory 
motifs, including feedback loops, 
Figure 3: BP is significantly faster than MC with 
comparable accuracy.  (A) BP converges three 
orders of magnitude faster than MC, even as the size 
of the system increases to 100 nodes. In this test, the 
number of training patterns equals the number of 
nodes in both BP and MC. (B) The means of the 
distributions from BP are plotted against the true non-
zero parameters from the set of the data generators.  
BP has a high correlation (R=0.7) with the true 
parameter values, with many points exactly on the 
diagonal. (C) MC and BP produce low errors per data 
point compared to random interaction assignments 
(Red bar). 
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single/multiple input motifs, multi-component loops and regular chains.  For this study, a 
drug was represented as a strong inhibition of a main target and smaller positive or 
negative effects on four or fewer other nodes, which were meant to simulate off-target 
effects.  Complete knowledge of the perturbations and off-target effects was used for the 
noise-free results, while only knowledge of the main targets was used for the noisy data 
results thus simulating inference on drugs with unknown off-target effects.  We simulated 
the system to steady state in response to each condition of 14 in silico drugs applied 
individually and in pairs.  The steady state profiles were recorded and used as the training 
data, while those conditions that oscillated were excluded.  
 
Ultimately, the predictive power of the inferred models can only be assessed by explicit 
simulation of individual models and comparison with experiment. However, the average 
value of the BP inferred probability distributions can be used in a descriptive sense and 
either guide human intuitive understanding of biological pathways or be compared to 
prior knowledge.  
 
The performance features for evaluating the inferred interactions were recall and 
precision.  Recall is the fraction of interactions from the data-generating network that 
were correctly inferred in BP generated probability distributions.  False negatives 
decrease the recall fraction.  Precision is the fraction of interactions inferred from 
probability distributions that were also in the data generator.  False positives lower the 
precision fraction. 
 
The average interactions as derived from belief propagation yielded a sparse network 
with a significant number of true interactions (Figure 4A).  Importantly, some incorrectly 
inferred interactions were not mutually exclusive of correctly inferred interactions.  That 
is, since each row of W was inferred independently (Assumption 2), one might expect a 
row to be either all correct or all incorrect, yet many rows in Figure 3B had both true and 
false inferences.   
Interestingly, false positives and false negatives are somehow structurally related.  In 
other words, BP tended to miss one or more true interactions (false negatives) and replace 
them with one or more compensatory interactions (false positives) that are structurally 
adjacent to the missed interactions. We observed three common structural correlation 
motifs, which we refer to as (a) upstream, (b) symmetric, and (c) co-regulation motifs 
(Figure 4B).  
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In the upstream motif, nodes A and C 
are connected through an 
intermediate node B, but an edge is 
inferred from A to C directly.  In the 
symmetric motif, a false positive 
connects two directly connected 
nodes but in the wrong direction.  In 
the co-regulation motif, node A 
directly regulates B and C separately, 
but a false positive exists between B 
and C directly.  In addition to being 
structurally correlated, the numerical 
correlation between nodes involved 
in false positives were observably 
high in the training data 
(Supplemental Figure S1).  
 
BP missed 17 of the 60 true 
interactions, giving a recall of 74%.  
Only 4 of these 17 false-negatives 
were not involved in one of the three 
structural correlation motifs.  
Meanwhile, BP predicted 37 false 
positive interactions for a precision of 
55%.  However, 29 of these were 
either involved in one of the three 
motifs or had a significant probability 
of being zero (and therefore ceasing 
to be false-positives). Consequently, 
we concluded that while many of the 
false positives may seem worrisome, 
they were supported in the data and 
in the underlying data-generating 
network.   
 
The results on this toy data 
confirmed that this implementation 
of BP had trouble disambiguating 
correlation and causation from 
steady-state data, which is a 
difficulty common in analysis of 
steady-state data [74]. BP inferred 
interactions between highly 
correlated nodes even if they were 
not causally connected.  BP was 
better able to infer causality when 
Figure 4: Detailed performance on a single synthetic 
data-generating network. The average parameters from 
the BP distributions are compared with the true 
interactions in the synthetic data generator. The color-
coded matrix (A) summarizes all inferred and true 
interactions. While BP recovers many of the true 
interactions, some of the interactions are missing (orange; 
false negatives) while others are incorrect (yellow; false 
positives).  We identified three compensatory motifs (B), 
which relate false positives to false negatives.  
Collectively, these classes of compensatory motifs 
contribute to most of the false negatives (C) and false 
positives (D).  In D, we’ve also included a category for 
interactions that have a significant probability of being 
zero (a non interaction).  Even in the presence of 
considerable noise, (E, F) a significant number of 
interactions are correctly captured and most of the falsely 
inferred edges participate in compensatory motifs. 
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there was sufficient perturbation of the nodes involved in a potential interaction.  
 
 It is likely that the assumptions inherent in this BP algorithm may be the root cause of 
the incorrect edge predictions, in particular, assumption 2, which decouples the likelihood 
function from the dynamics of the system. We expect that combining a tailored likelihood 
function to incorporate time-series data may dramatically improve the ability of a similar 
BP method to infer causality more efficiently. 
 
The inference of network parameters was moderately sensitive to noise.  With toy 
models, we could accurately analyze the effect that noisy data had on the accuracy of 
inferring network interactions.  Noise from measurement technology can have deleterious 
effects on network inference and introduce sensitivity to data outliers.  For example, 
RPPA produces Gaussian distributed data in the absence of substantial biological 
variability [75].  We estimated a coefficient of variance (CV) of 15% on the 
measurements from RPPA. To examine the effects of Gaussian noise on BP inference, 
we applied Gaussian distributed noise ( ) with a mean of zero and standard deviation 
of  representing the CV as in Equation 16. 
 
Equation 16 
 
 
We constructed two data sets with Gaussian noise; one with a realistic CV of 15% (
) and one with high CV of 30% ( ) as a worst-case scenario.  Though both 
recall and precision decreased with added noise (Figure 4E, 4F), the number of 
unexplained interactions stayed roughly constant. Importantly, BP was still able to 
identify key regulatory influences from the noisy steady-state data from sparse 
perturbations without any dependence on prior knowledge.  The performance on noisy 
data approached the performance of noise-free data when sufficient numbers of replicates 
were used in the training.  
 
This analysis of BP inferred interactions was limited to a thorough examination of a 
single set of interactions, taken as the average of each parameter from the BP generated 
distributions.  We have demonstrated that BP is fast, accurate and minimally sensitive to 
realistic amounts of noise.  Moreover, BP was sufficiently strong in distinguishing causal 
from correlated relationships even though we are currently limited to steady-state data 
from a small set of perturbation conditions.  We know how good the inference of 
interactions is in a scenario where a perfect model of the data generator exists.  The 
comparison gives us an idea of the structural plausibility of the interactions inferred in 
real biological contexts.   
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Network models of signaling pathways in melanoma cells 
The performance and accuracy of the BP algorithm in reconstructing artificial, 
biologically inspired models from toy data sets suggest that the BP algorithm may work 
for inferring useful predictive signaling network models from systematic perturbation 
experiments. The probabilistic nature of the BP algorithm is the key feature that enables 
de novo (without prior knowledge) inference on large and complex problems of cell 
biology, e.g., signaling processes involving more than a hundred molecular and 
phenotypic variables, which previous methods could not reach. Given this opportunity, 
we have applied this network pharmacology approach to SKMEL-133, a melanoma cell 
line resistant to a RAF inhibitor (Vemurafenib, PLX4032).   
Experiments:	  systematic	  perturbation	  of	  SKMEL-­‐133	  cells	  using	  drug	  pairs	  	  
We systematically perturbed SKMEL-133 cells with a panel of targeted drugs (Figure 5) 
used singly and in paired combinations. The cell lines were systematically perturbed with 
44 dual or single perturbations using combinations of 8 different drugs (Figure 5). The 
drugs were selected on the basis of their target specificity, availability and usability in 
clinical settings. The selected drugs predominantly target the PI3K/AKT and MAPK 
pathways, which are known to affect the response to RAF and MEK inhibitors in some 
melanoma cell lines and clinical samples [76,77,78,79,80].  Drug concentrations were 
chosen based on the effect of each single drug on a likely downstream effector of its 
target, e.g, as assayed using Western blot (Suppl. Figure 4). The changes to potential 
targets were measured with Western blot experiments in different drug concentrations 
and standard response parameters, such as IC50 values were determined from the dose-
response curve. (Supplemental Figure S4). For example, AKT inhibitor (AKTi) 
concentration was chosen based on reduction in AKT phosphorylation at S473 as 
measured by using Western Blot. The drug dose response curve indicated that ~5000nM 
of AKTi was required to reduce phosphorylation by 40%.  As a compromise between the 
competing requirements of gentle perturbations and observable effects, drug 
concentrations, at which the downstream effect of a single perturbation was reduced by 
40% relative to the unperturbed control were used in the paired perturbation experiments.  
The SKMEL-133 cell cultures were incubated for 24 hours upon drug perturbation to 
ensure a measurable physiological response interpretable as a steady state (details in 
Methods). The main intent of the systematic perturbations was to explore diverse aspects 
of the signaling response and for the experimental readout, such as protein 
concentrations, to be maximally informative about the couplings in a network model. 
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Figure 5: Systematic perturbation experiments. (A) Perturbation experiments with systematic 
combinations of eight small molecule inhibitors, applied in pairs and as single agents in low (light green) 
and high (dark green) doses. The perturbation agents target specific signaling molecules. (B) The response 
profile of melanoma cells to perturbations. The response profile includes changes in 16 protein levels (total 
and phosho-levels, measured with RPPA technology) and cell viability phenotype relative to those in no-
drug applied condition. 
 
Experiments:	  observation	  of	  response	  profiles	  in	  SKMEL-­‐133	  cells	  	  	  
After inhibition of one or two targets, we assessed the response to perturbation for each 
protein node xi by comparing the (phospho)-protein level at the presumed steady state to 
the level measured in identical experiments in untreated cells; and, similarly for cellular 
outcomes such as viability. We used an array technique (reverse phase protein arrays, 
RPPA [81]), in which cell lysates were interrogated by antibodies against proteins of 
interest.  Compared to Western blot assays, RPPA had the advantage of higher 
throughput, higher sensitivity, better dynamic range but the disadvantage of lack of size 
separation, which was addressed by using antibodies carefully tested for specificity. 
These were crucial advantages for the quantitative inference of network models. For each 
experimental condition, i.e., for each perturbation, three biological replicates were 
measured. The (phospho)-protein levels were quantified from spot intensities on the 
protein arrays and log normalized with respect to the corresponding protein levels from 
non-perturbed control experiments (response=log2(perturbed/unperturbed) ). Viability of 
the cells after drug perturbation was measured using a resazurin assay 72 hours after the 
cells were perturbed.  Overall, log ratios for 16 protein intensity readouts and the cell 
viability phenotype in 44 perturbation conditions constitute the training data for de novo 
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network inference, from a series of experiments using all combinations of 8 drugs (28 
experiments) and 2 drug concentrations for single drug perturbations (16 experiments), 
(Figure 5).  Cell viability measurements at 72hrs were used to ensure the phenotypic 
responses reached to steady state and significant phenotypic response was observed as a 
consequence of changes in relatively early proteomic responses to drug perturbations. 
Indeed, analysis of cell viability changes at 0, 24, 72 and 120 hrs after drug perturbations 
revealed no significant changes in cell viability at 72 and 120 hrs, whereas the cell 
viability change at 24hrs was not at steady state (data not shown).  
Concept	  of	  network	  models	  of	  signaling	  in	  SKMEL-­‐133	  	  
The proteomic and phenotypic (i.e., cell viability) response profiles to drug perturbations 
serve as experimental constraints for the construction of network models. We build 
network models of signaling pathways in the melanoma cell line SKMEL-133 to predict 
the response to inhibition in single and multiple protein targets. In the current 
implementation of this approach, non-linear differential equations of the system is 
defined by a set of nodes (scalar variables), such as molecular concentrations of proteins 
and phospho-proteins or scalar measures of cell behavior (such as viability, cell death or 
motility). The edges connecting the nodes represent the strength of potential (logical or 
physical) interactions between two molecular levels and between molecular levels and 
cellular outcome variables. We mathematically represented the network model by a set of 
ordinary differential equations, which describe the time behavior of the system following 
a perturbation from a well defined initial state. The edges are the system parameters to be 
optimized for maximal predictive power. Each measurement represented a constraint in 
the optimization algorithm. After derivation of optimal interactions parameters, the 
resulting network models quantitatively linked proteomic changes to each other and to 
phenotypic changes. We expected the network models to generate hypotheses about 
previously unidentified interactions, some of which may be accessible to biochemical 
experimental tests; and, to provide a quantitative, as well as intuitive, model of the 
signaling cascades in melanoma cells and to be useful for the prediction of nontrivial 
drug combinations (or single drugs) that may be effective in reducing cell proliferation 
and, in future work, in overcoming or preventing the emergence of drug resistance. The 
details of the mathematical model and the inference strategy are described in the Theory 
section. 
Leave-­‐k-­‐out	  tests	  of	  predictive	  power	  of	  network	  models	  
In order to test the accuracy and the predictive power of the models, we used a leave-k-
out validation strategy. For each leave-k-out test, we withheld data from k experiments, 
inferred network models on the remaining experimental data, predicted molecular 
responses corresponding to those in withheld experiments through numerical simulations 
and compared the predictions with the experimental observations in the withheld 
experiments. Specifically, for the SKMEL-133 cell line, network models were inferred 
using a set of perturbation experiments that includes paired combinations of 7 drugs + 1 
drug applied as a single agent in two different doses so that 7 unique combinations of the 
single agent are withheld. For each partial dataset, we generated 1000 network models 
with the BP guided decimation algorithm. Overall, eight sets of network models were 
generated by withholding experimental information for all possible combinations with 
one drug at a time, but using data from all single drug experiments. The network models 
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were numerically simulated using the model equation 1 and virtual perturbations 
mimicking the perturbations in withheld experiments to predict the proteomic and 
phenotypic responses to drug combinations. Response trajectories in time were generated 
for each read-out until the system reaches steady state and the predicted steady state 
response was computed by averaging the simulated steady state values over network 
models, using even weights for all 100 models with lowest error, for simplicity.  
Comparison of the predicted steady state response profiles for each condition with the 
values in withheld experiments indicated good agreement between the experimental and 
predicted response profiles (Figure 6). The correlation between the experimental and 
modeled response profiles at steady state was chosen as a simple measure of predictive 
power.   The comparison resulted in an overall Pearson correlation coefficient of 0.87 
(cross-validation error CV=0.05; see methods for definition of CV) between experimental 
and predicted proteomic and phenotypic measurements (Figure 6, Supplementary Figures 
S7 and S8), which we considered good to excellent. 
 
 
Figure 6: Predictive power of network models. Eight distinct leave-7-out cross validation calculations 
indicate a strong fit between the predicted and experimental response profiles. In each cross-validation 
experiment, network models are inferred with partial data, which lacks responses to all combinations of a 
given drug. Next, network models are executed with in silico perturbations to predict the withheld 
conditions. The cumulative correlation coefficient in all conditions between predicted and experimental 
profiles is 0.87 (CV=0.05). Few prediction outliers deviate from experimental values more than 1 σ 
(standard deviation of the experimental values, dashed lines). 
Interpretation	  and	  predictions	  from	  de	  novo	  inferred	  network	  models	  in	  melanoma	  cell	  
lines	  	  
Using our network inference algorithm, we derived a set of quantitative network models 
from paired perturbation experiments on SKMEL-133 cells.  The network models have 
25 nodes, i.e., 16 levels of proteins or phospho-proteins (phosphorylated on specific sites 
as indicated), one phenotype node corresponding to cell viability measurements and 8 
activity nodes, which quantify enzymatic activity.  
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Average network model as a guide. For simplicity of visualization, rather than 
attempting to visualize many individual models, a model representing averaged 
interactions, called the 'average network model', was constructed (Figure 7B) by 
averaging over the interactions in the set of 100 network models with lowest model errors 
among the 1000 instantiated models. Note that no quantitative prediction can be derived 
by simulation from the average model (see above for predictive power of the ensemble of 
solutions). However, the average model depicted the qualitative features of the solution 
space by reporting, for the most part, interaction values that were present at high 
frequency and amplitude in the solution space. Remarkably, as summarized in the 
average model, the network solutions captured the signaling interactions within the major 
pathways important for melanoma progression, e.g., well-accepted MAPK or PI3K/AKT 
pathways. In addition, the average model was suggestive of a series of additional 
interactions (see Supplementary Table S1 for details), some of which may represent 
novel biochemical interactions and may be good candidates for experimental tests 
('validation').  
 
 
Figure 7: The distribution of edges in all network models and average network model. The probability 
distribution of edge values (wij) after BP (A, left) are similar to the histograms of the corresponding 
interactions after decimation (A, right). An interaction strength is nonzero when it has high amplitude and 
frequency in solution space. We generate instantiated models with BP guided decimation algorithm 
followed by gradient descent optimization.  According to the agreement between the distributions in two 
panels, BP probability distribution and final model histogram are similar to each other with important 
exceptions. Thus, BP guided decimation algorithm goes beyond simply sampling from the BP models and 
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introduce features such as mutual exclusivity to the final models. (B) The average network model over best 
solutions (100 models) with lowest errors. The opacity of the edges scales with the absolute strength of the 
edges. The network diagram is shows the edges that have the highest amplitudes and frequencies in the 
solution set. The known interactions such as those in RAF/MEK/MAPK and PI3K/AKT pathway are 
captured by the inference method. 
 
 
Interpretation: AKT pathway. The canonical (known) PI3K/AKT pathway is 
characterized by a series of complex interactions resulting from the activity of the 
upstream kinase PI3K and reaching more downstream regulatory proteins [82]. Although 
the detailed spatiotemporal regulation of the PI3K/AKT pathway and its phenotypic 
output ranging from proliferation to metabolic changes are highly complex, our network 
models captured the major known interactions in this pathway. Our models described the 
pathways such as the AKT pathway only in terms of the observed nodes. The details of 
the models deviated from the intricate details of the known pathways due to the existence 
of unobserved nodes. As a natural consequence, the predictions that can be extracted 
from these models were also limited to the scope of the observed nodes and inferred 
model variables for those observed nodes. With the expansion of the observed nodes and 
perturbations, the network models may converge to the detailed pathway descriptions 
with additional strength of quantitative predictions.    
 
The indirect positive effect of PI3K on AKT phosphorylation, phosphorylation of TSC2 
on T1462 by AKT activity, the regulation of S6 and 4E-BP1 by the PI3K/AKT pathway 
were all represented in the inferred network models. In our model, mTOR activity (node 
amTOR, where a stands for activity, see Methods) has no allowed upstream node. This is 
due to our modeling approach, where activity nodes are quantified by the strength of the 
perturbations acting on them and to our experimental scheme, where no direct proteomic 
measurement is collected for the activity nodes (See methods for details).  However, the 
edge connecting TSC2pT1462 to 4E-BP1pS65 links the upstream components of the 
pathway to the downstream components and compensates for the lack of inferred direct 
interactions upstream (i.e. PI3K/AKT) to downstream components (i,e, mTOR) and leads 
to changes in downstream elements upon perturbation of the upstream components of the 
pathway. An inhibitory edge from mTOR to AKTpS473 in the PI3K/AKT pathway is 
reminiscent of the reported feedback loops in this pathway [83].  
 
Interpretation: MAPK pathway. In the RAF/MEK/ERK pathway, the inferred network 
models captured many of the known interactions that link the MAPK activity to 
CyclinD1 levels and RB phosphorylation [84]. However, the edges that link this pathway 
to cell viability were indirect through 4E-BP1 phosphorylation and had a relatively low 
effect on this phenotype (See below for a quantitative analysis). The inferred networks 
had a bidirectional interaction between PLK1 and CyclinB1 [85]. A strong direct 
interaction between PLK1 and cell viability was also in the models, consistent with the 
fact that PLK1 and CyclinB1 regulate the G2 to M transition in the cell cycle and PLK1 
has multiple roles in mitosis such as spindle formation [85]. 
 
Prediction: logical and biochemical interactions in the melanoma cell line. In 
addition to confirmation of known biological interactions in the de novo derived models, 
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the average model also indicates a series of potentially novel interactions. First, a strong 
bidirectional edge was observed between the phosphoprotein levels RBpS807 and 
MEKpS217 (<wRBpS807-> MEKpS217 > =  0.59, <wMEKpS217->RBpS807-> =  0.19). A direct 
interaction between RAF and Rb, phosphorylation of Rb by RAF and apoptosis induction 
upon disruption of this interaction have already been shown in melanoma [86,87]. 
However, the regulation of MEK phosphorylation by the inhibitory phosphorylation on 
Rb had not been reported in melanoma cells.  Interestingly, analysis of pituitary gland 
tumor formation in Rb and K-RAS double-knockout mice had suggested a genetic 
interaction between Rb and RAS, an indirect upstream regulator of MEK [88,89]. 
Moreover, in cell culture experiments, inactivation of Rb in murine fibroblasts resulted in 
aberrantly elevated RAS and MAPK activity, which was consistent with the positive edge 
observed between RbpS807 and MEKp217 [88,89]. A detailed molecular biology and 
genetic study is needed to determine whether the observed Rb/MEK bidirectional 
interaction is biologically relevant in melanoma or incorrectly modeled. Second, an 
inhibitory edge from the HDAC activity node to SrcpY527, a critical phosphorylation site 
for the auto-inhibition of Src [90] was consistent with the direct and indirect interactions 
of HDAC isoforms with Src observed in multiple cancer contexts [91,92]. Finally, 
positive edges connecting CyclinD1 and TSC2pY1462 to the SrcpY527 node were in the 
average model. No such interaction, nor any interaction that can compensate the observed 
edges, have been reported, to the best of our knowledge. The observed edges may 
correspond to logical interactions, i.e., via intermediate physical interactions not 
explicitly in the model, that coordinate a negative feedback loop acting on Src from the 
MAPK and PI3K pathways. All of the predicted interactions are suggestive of follow-up 
genetic and/or biochemical experiments.  
 
Prediction: target identification in the melanoma cell line via computation of 
viability changes in response to untested perturbations.  Once we had a set of network 
models of SKMEL-133 cells, we could predict the effect of arbitrary in silico 
perturbations acting on any protein node (concentration or activity) present in the model. 
Such in silico perturbations can be used to predict the quantitative effects of hypothetical 
drugs (i.e. virtual drugs that target the nodes in a model) on the cellular phenotypes; and, 
to quantitatively track signaling processes, beyond the qualitative interpretation of the 
average network model (Figure 6-Right). 
 
As an example, to nominate novel drug targets, we predicted the phenotypic (i.e. cell 
viability) response of SKMEL-133 cells to various perturbations by executing the model 
equation 1 with the parameters W determined from the experimental information. The 
simulations, for each of the 1000 network model solutions, yield the time progression of 
the concentrations of molecular species. In each simulation, a single perturbation was 
applied to a single protein node that reduces the activity of that node to 50%. The 
analysis of the phenotypic responses at steady state revealed that (separate) perturbations 
of 4 particularly interesting nodes, i.e, potential drug targets, resulted in the most 
significant alterations in cell viability (Figure 8).  
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Figure 8: Novel predictions with in silico perturbations. (A) The histogram of phenotypic response 
profiles to the four most effective virtual perturbations from the best 100 network models. The response to 
STAT3p705 reflects the effect of PKCi on cell viability. Viability changes in response to perturbations on 
cell cycle proteins PLK1 and CyclinB1 are genuine predictions from the network models. Perturbation of 
TSC2pT1462 (inhibitory phosphorylation) down regulates the PI3K/AKT pathway and leads to a decrease 
in cell viability in the PTEN null SKMEL133 cell line. (B) The perturbed nodes that lead to reduction in 
cell viability in the context of average network model (Circled in red). 
 
First, the most significant reduction in cellular viability was predicted in response to 
perturbation of STAT3pS705 (average log(relative cellular viability) = -1.16). In the 
network models, the STAT3 phosphorylation node was downstream of the PKC activity 
node and our perturbation experiments did show that PKC inhibition lead to low cell 
counts. Thus, the response of STAT3 inhibition reflected the effect of PKC inhibition, 
which was experimentally shown and used as an input in the training set. Next, 
perturbation of both PLK1 and CyclinB1 protein nodes (total protein level) lead to 
significant reduction in cellular viability (average log(relative cellular viability): -0.85 
and -0.69 respectively). PLK1 and cyclinB1 are two important cell cycle proteins 
regulating G2/M transition and highly specific PLK1 inhibitors are potential agents in 
targeted therapy [93]. Importantly, the network approach enabled us to predict the effect 
of PLK1 or Cyclin B1 perturbations on cell viability without having performed any 
experimental perturbation of these nodes. We tested this prediction by treating the 
SKMEL-133 cells with the PLK1 inhibitor (BI 2536) and measuring cell viability 
response with the Resazurin assay (Figure 9).  The experimental tests revealed that cell 
viability IC50 for the PLK1 inhibitor is 5.5nM in SKMEL-133 cells and that 
approximately 99% of the cells were killed with a 15mM concentration. 
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Figure 9: Experimental testing of computational predictions. Qualitative analysis of networks in in 
silico simulations nominated PLK1/CyclinB1 as potential targets to kill RAF inhibitor resistant melanoma 
cells. A validation experiment with the PLK1 inhibitor (BI2536)23 shows extensive growth inhibition in 
SK-MEL133 cells (Cell viability IC50= 5.8nm).  PLK1 inhibitor is a pure prediction of the approach and 
was not included in the experimental drug set. 
 
The fourth perturbation that yielded a significant change in cell viability was 
TSC2pT1462 inhibition, which had a central role in the inferred network models 
particularly in PI3K/AKT pathway. It was regulated by AKT phosphorylation and also 
interacts with MAPK14pT180, which was upstream of PLK1 and CyclinB1 in the 
models. Note that SKMEL-133 cell line is PTEN null and constitutively active 
PI3K/AKT pathway may play a role in drug resistance in this cell line. Thus it is not 
surprising to us that deactivation of a central player in this pathway leads to reduction in 
cell viability. The corresponding best drug target is the kinase that leads to 
phosphorylation of TSC2 on T1462. The effect of each of these four computationally 
perturbed nodes on cell viability either (i) was consistent with perturbation of 
immediately adjacent nodes already tested experimentally, or (ii) was a natural 
consequence of the genetic background of the tested cell line (i.e. PTEN null) or (iii) 
nominated a new drug target predicted to be highly effective and validated 
experimentally. 
 
Discussion 
Beyond classical molecular biology. Here, we describe a combination of experimental 
and computational methods, in the field of network pharmacology, to construct 
quantitative and predictive network models of signaling pathways. The particular 
contribution is a set of algorithmic advances, which we adapted from statistical physics to 
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infer network models in sizes and complexities not reachable by classical gene-by-gene 
molecular biology. The necessity of inference of complex network models stems from the 
fact that classical methods, in which a small number of perturbation experiments lead to 
functional description of carefully selected sets of genes and gene products is reaching 
technical limits. High-throughput proteomic and genomic profiling technologies provide 
much richer and more complex information about cellular responses than can be analyzed 
by a scientist's thought processes. At these levels of completeness and detail, predicting 
changes in physiological attributes from molecular data requires computational modeling 
and quantitative analysis. Our quantitative network models not only capture already 
known biological interactions but also nominate novel interactions and detect complex 
regulatory mechanisms, such as multiple feedback loops, in specific biological contexts. 
The quantitative analysis of molecular and cellular behavior in these models provides 
detailed understanding of the coupling between signaling processes and global cellular 
behavior. Such understanding is hard to achieve by reductionist approaches that focus on 
the relation between single or few molecules and cellular processes. Furthermore, we 
provide a systems biology platform to predict the cellular (i.e., proteomic and 
phenotypic) response profiles to multiple perturbations such as those in combinatorial 
cancer therapies,   
  
Network	   pharmacology	   in	   the	   era	   of	   personalized	   medicine. This investigation 
constitutes a proof-of-principle of a particular technology: a combination of a network 
inference algorithm and a technology for perturbing cells and measuring their response. 
The overall context is network pharmacology, by which we mean the science of using 
network models to derive and then test effective therapeutic combinations. The particular 
challenge, in cancer biology, is the complexity and individual variation of genetic and 
epigenetic alterations that are plausibly cancer-causing and modulate the response to 
therapy; and, the emergence of resistance to successful targeted therapies, such as EGFR 
inhibitors in lung cancer or RAF inhibitors in melanoma. In our view, the fairly 
fragmented gene-by-gene classical methods of molecular biology, while extremely 
powerful as a reductionist method, are reaching a clear limit. Such methods struggle with 
effects such as "cross-pathway coupling", "multigenic diseases" or individual variation of 
response to therapy. More comprehensively quantitative and computationally predictive 
methods ("systems biology") are likely not only to increase our predictive abilities but 
also save substantial overall effort by computationally testing large numbers of cellular 
states on a large variety of genetic backgrounds and in exhaustively explored perturbation 
conditions. 
 
Power and limitations of the belief propagation method for network modeling of 
signaling pathways. The implementation of BP algorithm enables us to infer much 
larger network models than were reachable with Monte Carlo search methods. First, we 
used biologically realistic toy data to illustrate the dramatic speed improvement of the BP 
method over standard Monte Carlo methods.  BP convergence times scale favorably with 
the size of the models at no measureable loss of accuracy.  This is a desirable property for 
constructing large network models de novo.  Even in the biologically realistic conditions 
of noisy data from sparse perturbations conditions, BP inferred most of the dominant 
interactions in the data-generating network. Though a fraction of the likely BP 
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interactions were false positives, these false positives are consistent with the data and 
connect structurally correlated nodes. The assumptions inherent in this BP 
implementation are potential limitations to the overall efficacy and accuracy of our 
approach.  However, assumption 1, while important, does not dramatically affect the 
results beyond a threshold discretization resolution.  Furthermore, since BP performed as 
well or better than MC, which employed neither assumption 3 nor 4, we suspect by 
process of elimination that assumption 2 is the largest contributor to the observed 
limitations of our current method. For real biological data, the quality of BP’s 
performance depends on the applicability of the model equations and the richness and 
quality of the perturbation data used for training.  
 
We have previously published an MCF7 breast cancer cell line dataset, for which 
network models were inferred with a nested Monte Carlo search algorithm (CoPIA) [94].  
Reassuringly, many of the strongest interactions from CoPIA are recovered by the BP 
method (Supplementary Text-S2, Figure S10). We have also modeled the same SKMEL-
133 dataset with Gaussian Graphical Models, a popular probabilistic model that goes 
beyond pairwise correlations to distinguish between direct and indirect correlations. A 
comparison to the BP derived interactions suggests non-trivial overlap in the strongest 
couplings. A more detailed analysis is available in the supplement (Supplementary Text –
S3, Figures S11 and S12). 
 
Confirmed and predicted interactions in malignant melanoma cells. We have been 
able to capture the known interactions in MAPK and AKT/PI3K canonical pathways 
through de novo network modeling. Moreover, we predicted potential logical interactions 
such as a bidirectional interaction between RB and MAPK pathways and a potential 
feedback loop from PI3K and MAPK pathways acting on Src activity through inhibitory 
phosphorylation at SrcpY527.  We determined the signaling events, which influence the 
cell viability phenotype with in silico perturbations. The quantitative analysis reveals that 
three signaling events have considerable influence on the cell viability. The in silico 
perturbations of CyclinB1 and PLK1 lead to comparable reduction in cell viability. As 
neither CyclinB1/PLK1 nor their direct regulators were inhibited in the perturbation 
experiments this result is a nontrivial prediction. We also tested and validated this 
prediction by measuring the cell viability after treating melanoma cells with a potent and 
selective PLK1 inhibitor. As validated by experimental tests, PLK1 inhibitor reduces 
cellular growth significantly in melanoma cells even when treated with the drug at 
nanomolar concentrations (Figure 9). Moreover, none of the in silico perturbations of the 
MAPK pathway lead to a significant change in cell viability, which is consistent with the 
experimental responses to perturbations acting on MEK and BRAFV600E and RAF 
inhibitor resistance of SKMEL-133 cells. 
 
The problem of drug specificity.   We are aware that drugs do not usually have a single 
specific target.  While this is potentially problematic for modeling and simulating drug 
effects, we find that the inference is driven largely by the correlations in the data arising 
from the effect of perturbations on the overall system. We estimate that BP is most 
sensitive to strong and untrue assumptions about the direct effects of a given drug. The 
use of ‘activity nodes’ is an indirect way of dealing with drug off-target effects.  These 
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nodes, which are perturbed but not measured, represent the coupling of a drug with rest 
of the system. Such coupling includes both specific and off-target effects.  BP may infer 
interactions from these activity nodes to any other measured node thus representing 
multiple targets for the drug used.  Drug specificity also affects the predictive power of 
the resulting models.  All effects from the AKT inhibitor, for example, are assigned to 
single knockdown of the aAKT node, even if other targets of the AKT inhibitor are 
partially responsible for the measured outcomes.  Therefore, any simulation-based 
prediction regarding perturbation of the aAKT node will be tethered to the off-target 
effects of the AKT inhibitor used in training. The complete solution of the drug 
specificity problem requires a more comprehensive and systematic analysis to determine 
the effect of off-target effects on quality and predictive power of inferred models. 
 
Failed predictions and optimal design of experiment. The detailed analysis of the 
predictions reveals few outlier points, where the prediction of the response profiles from 
incomplete datasets fails. These outliers are in two major categories. In the first category, 
(mis)predictions arise due to  measurements with very low signal to noise ratios and high 
experimental uncertainties. The mis-predicted S6pS240 levels and cell viability 
phenotypes in some of the perturbation conditions fall into this category. Note that the 
models are trained and simulated after logarithmic conversion (i.e. the readouts are first 
normalized to their counterparts in no-drug conditions and the log-2 of the ratio is 
computed), which exaggerates the errors for low signals. In linear space (i.e. when all 
values are converted back to linear space) no such outliers are observed suggesting that 
those outliers can be considered as an artifact of our analysis in logarithmic space. In the 
second category, (mis)predictions arise due to insufficient experimental constraints. 
(Mis)predictions of  AKTpS473 levels after mTOR inhibition falls into this category. 
mTOR inhibition leads to an increase in AKT phosphorylation possibly due to the 
disruption of a feedback loop.  In our current analysis, mTOR inhibition and steady state 
measurements on AKT phosphorylation are the sole experimental inputs to detect the 
changes in this feedback mechanism.  When the mTOR inhibition is withheld in leave k-
out calculations, experimental constraints become insufficient to describe the regulation 
of  AKT phosphorylation leading to the (mis)predictions. A systematic experimental 
design to enrich the perturbations, better characterization of the AKT phosphorylation 
dynamic range and richer proteomic measurements on this part of signaling pathways are 
possible ways to improve the quality of these particular predictions. In general, careful 
optimization of perturbation conditions (drugs, shRNA) and observations (protein arrays, 
mass spectrometry target list), within available resources, would significantly enhance the 
predictive power in this type of model. 
 
Predicting effective novel drug combinations with BP based network modeling. 
Predicting the effect of drug combinations is highly challenging and has been the subject 
of many studies, e.g., [95,96](Geva-Zatorsky et al, 2010 ; Gupta et al, 2010). When a 
large repertoire of targeted drugs are available for screening, the search space for useful 
combinations of two or more drugs is combinatorially complex.  Moreover, 
therapeutically promising drug combinations are not limited to simultaneously introduced 
perturbations.   Potentially useful drug combinations may consist of combinations of 
relative doses, for two, three and four drugs applied simultaneously or sequentially after 
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well-defined time intervals. Identification of such more complicated combinations 
through experimental screening tests is prohibitively cumbersome. Here, we provide a 
potential solution to this problem in that in silico screens using predictive network 
models can cover a large space of possible drug combinations. The predictive power of 
the models derived here is apparent from the reasonable accuracy of predicting the results 
of withheld experiments using a leave-k-out cross validation procedure. Network models 
inferred from series of perturbation experiments can thus be used to predict the responses 
to novel combinations, which were not or have not yet been experimentally tested. One 
can enlarge the search space for drug treatments from a few hundred experimentally 
screened combinations to tens of thousands of computationally tested combinations and 
guide subsequent highly efficient top-candidate experimental screens. 
 
Beyond the computational power of well-constrained and robustly derived network 
models, one may expect to achieve a conceptual understanding of the principles of 
epistasis of drug effects and the mechanisms of resistance to targeted therapeutics. For 
example, the initial 'network' response to drug intervention on the scale of minutes to 
days may be indicative of subsequent epigenetic and genetic changes in a population of 
treated cells that represent the long-term and hard-to-treat emergence of drug resistance. 
In this context, reliable dynamic network models may be an excellent guide to strategies 
for blocking the emergence of resistance in the first place. The pre-clinical consequence 
is the selection of combinations of therapeutic interventions that not only are effective in 
slowing the proliferation or promoting the elimination of cancer cells, but also are good 
candidates in clinical trials aiming to counteract resistance to otherwise effective 
treatments, such as RAF inhibitors in melanoma or AR inhibitors in advanced prostate 
cancer. 
 
Method improvement.  While the approximate solutions to the problem of network 
inference deliver interpretable biological results, there is much room for improving the 
power and information value of the method. For example, when time-dependent response 
measurements after perturbation are available, one can use analogous, extended 
algorithms to infer probability distributions over (time-independent) interaction 
parameters W that describe the behavior of a time-dependent system. Another extension 
of the formalism is the use of more complicated forms of the differential equations, such 
as those of enzyme kinetics. Also, even in the current approximation, careful design of 
experiments selecting a minimal set of maximally informative perturbation conditions 
would increase the efficiency of this experimental-theoretical approach.  
 
A straightforward and powerful extension is the systematic use of prior information, in 
the form of quantitatively expressed network models adapted from the current scientific 
literature or pathway databases. Such prior information is easily incorporated as a set of 
additional constraints on the probability distributions over W in the cost function 
(Equation 3). We are also actively pursuing a method for the systematic inclusion of prior 
knowledge interactions from curated databases. On the experimental side, measurement 
of richer phenotypic attributes of cells, such as apoptosis or cell cycle arrest, as well as 
markers of differentiation states would much increase the predictive power by providing 
more links between molecular and phenotypic quantities. 
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The network pharmacology approach described here provides a strong tool for a system 
level description of signaling events in cancer cells and moreover, it presents a step 
forward in quantitative prediction of responses of cancer cells to drug perturbations.  
Beyond cancer biology, there is no reason to believe that the proposed technology cannot 
be used to derive accurate quantitative and predictive network models for biological 
cellular systems in general, provided sufficiently diverse experimental perturbations 
(such as systematic shRNA) and sufficiently rich readout (such as protein mass 
spectrometry, metabolic profiling and cellular image analysis) are accessible. In this way, 
we hope to extend the power of classical molecular biology to a broad spectrum of 
cellular systems with targeted, and possibly clinical, applications. 
 
Methods and materials  
Materials	  	  
Choice of drugs and drug concentrations. Eight small molecule drugs targeting mainly 
the MAPK or AKT/PI3K pathways were chosen based on the knowledge of target 
specificity and relevance for exploring BRAF signaling in SKMEL-133 cells (Figure 5). 
In order to select an appropriate drug concentration for the RPPA assay, Western blots 
were used to measure the dose-response effect of each drug on its the presumed targets or 
downstream effectors (Supplementary Figure S4).  
 
RPPA and Western blots. For Western blotting and reverse-phase protein arrays 
(RPPA) assays, BRAFV600E mutant SKMEL-133 cells were grown in 6-well plates to 
around 40% confluence in RPMI-1640 medium containing 10% fetal bovine serum 
(FBS). In a series of perturbation experiments, cells were perturbed with 8 drugs either 
singly or in paired combinations, and harvested after 24 hours by collecting and freezing 
the cell pellet. Non-perturbed control cells were treated with drug vehicle (DMSO) for 24 
hours (elsewhere called "no-drug control"). Cells were thawed, lysed and protein 
concentrations were determined by the Bradford assay. Protein concentrations were 
adjusted to 1-1.5 mg/mL and proteins denatured in 2% SDS for 5 minutes at 95°C. For 
RPPA, cell lysates were spotted on nitrocellulose-coated slides in Gordon Mills’ 
laboratory at MD Anderson Cancer Center, as described previously [81] and stain with 
antibodies. Each sample was represented in triplicates originating from three different 
biological samples (wells). The resulting antibody staining intensities are quantified using 
the MicroVigene automated RPPA module (VigeneTech, Inc.) and normalized as 
describes in [81]. 
 
Resazurin cell viability assay.  Cells were grown in 6-well plates and perturbed same as 
those in RPPA assays. After 72 hr drug treatment, resazurin (Sigma-Aldrich, Catalog # 
R7017) was added at a final concentration of 44 µM to each well and the fluorescent 
signals were measured after 1 hr incubation, using 530 nm excitation wavelength and 590 
nm emission wavelength. For control wells (0hr drug treatment), the fluorescent signals 
were monitored after 4hr incubation.  Standard curves of cell numbers were generated as 
well to back calculate the cell numbers in different wells. 
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Setting up belief propagation calculations for network inference. Network models are 
constructed using the measured proteomic and phenotypic response profiles to drug 
perturbations as experimental data. The reported network models contain 25 nodes and 
are based on 44 experimental constraint sets. Each measured protein level is log 
normalized with respect to its measured level in the corresponding no-drug control 
condition. For quantification of the activity nodes, see below. The probability distribution 
for each possible edge strength in the system is computed using the belief propagation 
algorithm. In the current implementation, the edge strengths can assume values within the 
interval [-1, 1] with discrete steps of 0.2. The initial messages are sampled uniformly 
from a random distribution and the BP algorithm is run until the difference between 
messages in consecutive iterations is less than 10-6. A systematic approach is taken to 
ensure the right approximate connectivity in the network models in order to prevent both 
non-descriptive, sparse models and over-fit, highly connected models. Very sparsely 
connected network models have discontinuities in information flow and low predictive 
power. Over-fitted models lack generalizability of predictive power. Empirical 
representations of signaling networks in the extant literature are fairly sparse, with 
approximately 1-2 edges per node. We take guidance from these generally intuitive 
models and aim for an average of about ~1.5 edges/node as desired order of connectivity 
in the instantiated network solutions derived here.  The temperature scaling constant β 
and the complexity penalty term λ are the parameters in the BP algorithm that influence 
average network connectivity. To reach the desired order of connectivity, these two 
coefficients are adjusted using a series of systematic belief propagation (BP) calculations 
with β and λ in the interval (0, 5.0]. In each BP calculation, the most probable value 
observed in probabilities is assigned as the edge value, for each interaction; this allows 
the calculation of the total number of edges with non-zero values and thus of the average 
connectivity. As a result, β and λ values are chosen such that the desired level of 
connectivity is ~1.5 edges per node. These values (β=2, λ=5) are used for the 
computation of the instantiated solutions in subsequent decimation calculations.  For each 
node,  is taken as 1 and  is estimated from the dynamic range of each proteomic 
measurement sampled in the biological dataset. The  and  parameters are further 
optimized with a gradient descent algorithm. 
 
 
Inferring distinct, executable network models of signaling. Next, distinct model 
solutions are computed with the BP-guided decimation algorithm. The edge parameters in 
each model are further optimized using the Pineda/gradient descent algorithm [33], 
relaxing the assumptions of discrete edge values and factorized probability distributions 
(Equation 7d). This gradient descent algorithm includes optimization of both εi  and αi  
parameters. The optimized models are ranked according to their model errors and the best 
100 models are used to compute averages of predictions and the graphical representation 
of the set of best solutions as the average network model (Supplementary Figure S6).  
The average network model is for summary and illustration purposes and is not in itself 
executable. Instead, prediction are made by simulation of individual, or sets of, 
instantiated network models.  
αi εi
εi αi
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Simulating signaling network models. Each network solution is simulated individually 
with specific virtual perturbations according to the model equation 1 until the system 
reaches its steady state (Supplementary Figure S9) (i.e. until no system variable changes 
in consecutive steps of simulation within machine precision). The DLSODE integration 
method (ODEPACK) [97] is used in simulations (default settings with, MF =10, ATOL= 
1e-10, RTOL=1e-20) is used for simulations. Trajectories for the best 100 model 
solutions yield an ensemble of predicted outcomes in response to in silico perturbations.  
 
Activity nodes. "Activity node" is a technical term defined within the context of applied 
perturbations and derived network models (Figure 7-Right, Supplemental Figure- S15). 
Each activity node quantitatively represents a molecular process or reaction, such as 
phosphorylation, involving a particular protein (or other signaling molecule) that is 
affected by a perturbation agent. Since we measure protein and phospho-protein levels 
and do not directly measure the biochemical activity of any kinase, the activity nodes 
stand in for the effect of each drug perturbation on the biochemical activity of the drug 
targets. At a basal level (no perturbation), the quantitative measure of an activity node is 
equal to the activity level in 'no drug' control experiments and is set equal to 0 as a 
reference point. In the presence of an inhibitor molecule affecting a particular activity 
node, it is calculated based on the influence of the drug on its presumed immediate or 
downstream target validated with Western blot experiments (Supplementary Figure S4). 
We demonstrate this with an example (i.e., quantification of the MEK activity node 
(aMEK)). We measure the strength of a MEK inhibitor by measuring the phosphorylation 
of its downstream target MAPK1 at residue T202.  If the level of MAPK phosphorylation 
inhibition is 55% compared to a 'no drug' condition, the strength of the inhibition is 
ui=log2(0.55)=-0.863. Based on the model equations (Equation 1), the value for the 
activity node is Xa= (β/α) tanh(ui)=-0.697. The α/β is initially assumed to be 1 and refined 
by the final gradient descent optimization step. Activity nodes are not allowed to have 
any upstream regulators except the inhibitor since we do not have any direct 
measurement of the activity node. All of the activity nodes are quantified using the above 
procedure and the responses from presumed targets. 
 
Mathematical description of perturbations. A constant perturbation (ui) acting on a 
particular node i (Equation 1) has an impact on both the time derivative and the final 
steady state value (xi) of the perturbed node. The set of interactions and their values (wij ) 
are independent of the perturbation. As modeled by Equation 1, the dynamic properties 
and steady state value of node xi are a function of the combination of influence from all 
upstream nodes (xj) connected to node with nonzero wij and the strength of the 
perturbation. The perturbation term in Equation 1 models the effect of targeted 
interventions such as targeted small molecules. The model equation can also incorporate 
other perturbation forms such as genetic alterations or RNA interference (RNAi). In case 
of genetic alterations, the impact can be modeled by fixing xi to a desired value. For 
example, fixing a particular xi value to 0 accounts for a homozygous deletion in the 
corresponding gene. One may also fix the value of xi  to a positive value to model the 
impact of amplification of a gene product (e.g., DNA copy number change). RNAi 
perturbations can be modeled similarly to targeted drug perturbations. The perturbations 
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with varying siRNA concentrations have a direct impact on both time derivative and 
steady state values of its targets. RNAi perturbations, however, would influence all nodes 
associated with a particular gene (e.g., total level, level of phosphorylated gene product) 
since the system is perturbed at the gene expression level. 
 
Toy Data:  We generated toy data based on toy network models in order to test the 
performance of BP against a known set of true interactions. The toy models are generated 
by first fixing a topology positive and negative values, which are then assigned a set of 
real values by drawing from an even distribution between 0 and a maximum strength of 
2.  The topologies are designed to represent cascade-like hierarchical networks to include 
parallel chains, feed-forward and feedback motifs.  For the analysis focusing on true 
interactions, the topology was generated with the web-service Gene Network Generator 
(GeNGe).  At the time of this analysis, popular toy data generators such as 
GeneNetWeaver focus on scale-free like network topologies that are common in gene 
regulatory networks, but not typical for signal transduction pathways. Given the network 
model, the data is generated by simulating the model according to Equation 1 in response 
to external perturbation, until the system reaches a stable steady state.  The steady state 
values for all nodes are recorded in each perturbation condition.  In rare cases, the 
simulations encountered perpetual oscillations and these results were excluded from the 
final toy data set.  These simulations are purely deterministic as no stochasticity was 
incorporated into the simulations. Noise was added to the data post-simulation.  We 
chose to simulate the dynamics of the toy networks with Equation 1 so as to remove as a 
source of error the suitability of Equation 1 as a suitable model of the underlying system. 
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Supplementary material to: Perturbation biology- inferring 
signaling networks in cellular systems. 
 
 
 
Figure S1: Comparison of the correlations between false-positives and true-
positives. The nodes connected by false positive edges inferred by BP tend to be highly 
correlated (blue dots in Figures S1A and S1B), as analyzed here for two example false 
positives, each from different false positive motifs.  Indeed the falsely connected nodes 
seem to have stronger correlation than the nodes connected by real edges (red and green 
dots).  This analysis indicates that BP is indeed capturing significant correlations in the 
data although through false interactions. It also indicates that the edge parameters that BP 
misses (red and green edges) are somehow compensated by the false positive parameter 
(blue edges). In the absence of temporal data or more perturbations of the nodes in this 
sub-network, there may not be sufficient evidence to correctly infer the causal 
relationship between these connected nodes. 
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Supplementary Text S1: BP accuracy on better data 
In this short analysis, we wanted to investigate the effect that perturbation strategy has on 
the performance of the BP data.  Currently, we use a set of drugs targeting a subset of all 
model variables and apply them individually and in all possible pairs to generate the 
training data (Pair Perturbation Data). We wanted to compare this strategy against so-
called higher order perturbations, where many nodes are simultaneously perturbed in a 
single experiment (Extended Perturbation Data).  In each experiment, up to five nodes are 
randomly selected for perturbation.  Furthermore, the set of targetable nodes are restricted 
to the same set as for the pair perturbation data.   This study is performed entirely on a 
single toy model (the same 40 node network as that analyzed in the main manuscript), 
simulated to steady state for each perturbation condition described above.  The steady 
state responses were subsequently used to infer the interactions of the underlying data-
generating network.   
 
The training patterns that emerged from the pair perturbation strategy tend to be highly 
correlated, such that most pair combinations provided little unique information.  
Conversely, the extended perturbation data set produces less correlated training patterns 
(Figure S2E,).  It is clear that the training patterns with higher median correlation would 
have less information than the training patterns with lower correlation.   
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Figure S2: Alternative higher-order perturbations produce better data for inference 
with BP than the systematic pair perturbation strategy. Performance for both datasets 
is analyzed with mean squared errors (A), recall (B), precision (C), and the total number 
of BP-inferred interactions. The correlations between the training patterns are shown in 
analyzed in (E) for both perturbation strategies. 
 
 
We subsequently evaluated recall and precision (Figure S2B,C respectively) of the BP 
models trained to the two data sets.  The BP models from the extended data set reach a 
higher recall and do so faster than for the pair perturbation data.  Similarly, the precision 
curve for the extended data set lies consistently much higher than for the pair perturbation 
set. Finally, as we increase the number of experiments from the pair perturbation data set 
(by allowing additional nodes to be targeted) we definitely see that we get new 
information about the true interactions since the recall curve goes up. However, the novel 
information per additional experiment is fairly low and yields networks with increasing 
numbers of interactions. These three results confirm that using BP against more 
informative data produces superior network model, and that different strategies of 
perturbing the system yield training patterns with different information. 
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Although we see similar correlations between pair perturbation datasets in biological 
experiments (data not shown), it is not clear if the alternative strategy proposed here that 
works on the synthetic data generator would hold in the biological setting due to 
unexpected drug-drug interactions. 
 
Figure S3: Perfect BP inference with ideal data. Totally randomized data (A) produces 
low correlations between training patterns (B).  With this maximally informative, BP 
reproduces all of the true interactions (D), except 2 with zero false positives when 
compared against the underlying data generating network (C). 
 
Furthermore, we were interested in looking at BP results when Assumption 2 is not at 
play.  There are many assumptions in the BP method described in the main manuscript. 
One of the most dangerous assumptions is Assumption 2, which decouples the likelihood 
function from the dynamics of the model parameters.  The synthetic data sets analyzed in 
the manuscript were generated without assumption 2.  In those tests, we see good but 
imperfect inference of the underlying interactions.  To isolate the consequences of 
assumption 2 and assess the performance of BP when assumption 2 is exact, we have 
generated this artificial data set (Figure S3A), which is not based on dynamic simulation 
of the generator network.  Instead, we generated 300 training patterns for each model 
node separately as in Equation 5. We use random, uncorrelated values for the values on 
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the right hand side of Equation 5 to generate values on the left hand side. The result is a 
set of low training patterns with low correlation (Figure S3B).  Inferring network 
parameters with BP from this data produces near perfect inference with zero false 
positive and only 2 false negatives (Figure S3D). Although this type of data is infeasible 
in any biological system, it demonstrates that BP works almost perfect in the extreme 
case of ample, ideal data.  This result also reinforces our suspicion that the effect of 
Assumption 2 is most likely responsible for the observed limits in BP performance. 
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Figure-S4: Dose response curve of singe agent drug perturbations.  
Dose response curves determined based on Western Blot experiments, shown on top. See 
table S1 for protein IC40 values, which are calculated with these curves and  used in all 
paired perturbation experiments . Cell viability curve (not shown) was used to estimate 
PKC inhibitor (Ro-31-7549) IC40. 
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Figure - S5: Model abstraction in network models of signaling.  A relatively detailed 
model of biochemical events in PI3K/AKT pathway (i.e. consecutive phosphorylation of 
AKT at T308 and S473) (reactome.org) and the coarse-grained network model 
abstraction used in this paper (Red arrows and rectangles).  In the model abstraction, 
PI3K and AKT activity nodes influence  the final output of the activation mechanism (i.e. 
AKTpS473). In princible, we can improve and extend the model with additional 
measurements such as measurements on PDK1, AKTp308 (circled in gray) etc without 
altering the model abstraction.  Such model improvement requires richer measurements 
and   will lead to a  shift from logical to potential physical interactions. Lower left. The 
PI3K/AKT interactions in the average network model computed with BP-guided 
decimation. 
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Figure - S6: 6 of the 10 best network models. Better models have lower cost. Two 
nodes (horizontal and vertical list) can be connected by a positive (red) or negative (blue) 
interaction Wij. Although each model is different in detail, each model represents the data 
well in the predictive sense. The differences reflect genuine uncertainties of model 
inference, normally not represented in molecular biology cartoon models. 
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Figure - S7: Predictive power tested by prediction of withheld data. The 8 distinct 
heatmaps of withheld (upper right) and predicted (lower right) respone profiles to 
withheld perturbations (upper left). For quantitative analysis of predictive power, please 
see Figure 7 in the main manuscript. 
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Figure - S8: Cumulative predictive power. The cumulative scatter plot that combines 
the information in Figure S7 (C=0.87). 
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Figure - S9: Sample simulated trajectory. Pseudo-time trajectory of a single network 
model when perturbed with an in silico perturbation on AKTpS473 at virtual IC50 .(i.e. 
log2 ([AKTpS47 ]final /([AKTpS47 ]initial)=-1) 
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Supplementary Text S2: Results on MCF7 data set 
 
We previously published a different inference algorithm, called CoPIA [94], which was 
applied to a small data set collected on mcf7 breast cancer cell linesl. The data set 
consists of 9 measured protein and phenotype responses to  
21 perturbation experiments involving 7 drugs.  In brief, CoPIA consists of a nested 
search, in which the outer loop searches over network topologies, while the inner loop 
optimizes the parameters of that topology with a gradient descent algorithm. Both CoPIA 
and BP are based on the same model equation as defined in Equation 1.  The likelihood 
function employed in the CoPIA method is a function of explicit numerical simulation, 
while the likelihood function in BP is based on an algebraic approximation of the steady 
state, as discussed in Assumption 2.  In this short study, we applied our BP based pipeline 
on the same mcf7 data and compare the results.  In this analysis, we used only a single 
beta (inverse-temperature) and lambda (sparsity) penalty.  The BP results are based on 
the top 100 models from a set of 10,000 models generated from the BP-calculated 
marginal distributions. The CoPIA results were taken from the edges reported in Table 1 
in [94].  
 
BP returns many of the significant interactions determined by CoPIA (Figure S10A), 
where the edge widths are proportional to the estimated posterior probability from the top 
100 CoPIA models.  Of all 23 interactions inferred by CoPIA 13 interactions are 
observed in at least 2 of the top 100 models sampled from BP-calculated marginal 
probability distributions.  Five of the ten excluded interactions were not eligible for 
inference with BP (blue edges), since BP considers neither self-interactions nor edges 
directed into ‘activity nodes’.  Thus only 5 interactions, only 2 of which were high 
probability edges in CoPIA, are excluded by BP. 
 
BP infers 27 parameters (Figure S10B) with a probability of greater than 20%, of which 8 
are also interactions in the top 100 CoPIA models (green). Edge width in the bottom 
figure is proportional to their frequency in the top 100 BP models.  Of particular interest 
is the large number of high confidence incoming edges into MEK and pERK, both of 
which were inferred to have self-feedback interactions in the CoPIA models (11 between 
those two).  It is also interesting that with the exception of an inhibitory interaction 
between pERK and MEK, there are no high confident interactions originating from either 
pERK or MEK. We do not yet understand why this happens, but we suspect there is a 
pathological connection between their high connectivity in BP and the inferred self-
connectivity in the CoPIA models.  Finally, the top 100 BP derived models have a mean 
squared error of roughly 0.1, which is as low as we’ve seen.   
 
There is significant agreement among a subset of high confidence edges.  This suggests 
that both BP and CoPIA methods have explored similar areas of the total solution space. 
However, BP does not return the exact same models as CoPIA. There are many potential 
reasons why the results are different.  The first possibility is that BP’s restriction to 
exclude self-interaction and edges into activity nodes forces BP to search in an alternative 
region of solutions space.  Secondly, CoPIA is based on a fairly simple MC topology 
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search, which is unlikely to explore much of the full solution space.  Consequently, the 
CoPIA results might well reflect a local-minima in the solution space.  Regardless, the 
low mean-squared-error of the top 100 BP models is a positive result. 
 
Figure – S10: BP comparison with CoPIA results on mcf7 perturbation data.  The 
CoPIA network inference method is an older method based on a nested Monte Carlo 
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search, and was previously applied to infer network models of mcf7 breast cancer data.  
The CoPIA network edges are color-coded based on the existence of those edges in BP 
inference (A) has many agreeing edges (green).  Furthermore, most of the significant BP 
edges (B) are also significant in the CoPIA models (green).  
 
Supplementary Text S3: Comparison with Gaussian Graphical Models 
 
Gaussian Graphical Modeling (GGM) is a well-developed model for describing couplings 
between random variables  [98,99]Correlation based networks are typically found to 
poorly distinguish between direct and indirect associations. Gaussian models are 
theoretically based on conditional dependencies in multivariate Gaussian distributions, 
and are likely to better distinguish between direct and indirect associations.  Like 
correlations, couplings in GGMs are symmetric between model variables, and thus the 
couplings do not distinguish direction. We have adapted standard methods of calculating 
GGMs, based on inverting the covariance matrix, to infer couplings not only between 
model variables, but also between drugs and their targets (presuming the targets are 
included in the set of model variables), denoted J and H respectively.  We use a standard 
maximum-likelihood estimator to calculate both J and H simultaneously. The goal of this 
brief study was to compare the strongest couplings from GGMs against those inferred by 
BP. 
 
The results are summarized in this figure.  The GGM calculation is dependent on a single 
parameter, referred to as the weight cutoff, which reweights the training patterns (in this 
case, perturbation experiments).  The cutoff is constrained to be less than or equal to 1, 
and a cutoff of 1 corresponds to zero reweighting of the patterns.  We find that a cutoff of 
1 results in the highest likelihood model, given the data (Figure S11A) and the J and H 
matrices analyzed here are the result of this cutoff.  The distributions for both J and H 
coupling strengths (Figure S11B and S11C, respectively) have the majority of strengths 
on or near zero, which indicates strong discerning power between strong and weak 
couplings.  
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Figure - S11 : Gaussian model couplings for the most likely cutoff. The inference with 
no reweighting produces the highest likelihood estimate (A). The distribution of J and H 
couplings (B and C, respectively) are strongly centered at zero, demonstrating some 
discerning power between all possible couplings.  
 
To assess the extent of agreement between GGMs and the BP interactions we must 
decide where to fix the threshold, below which all J and H couplings are set to zero and 
thus ignored as edges in a network.  If the threshold is too high, we end up with a very 
sparse network with only the strongest couplings.  If the threshold is too low, all variables 
are coupled and we lose any ability to discern between strong and weak couplings.  The 
agreement with varying threshold is summarized with the Receiver Operator 
Characteristic (ROC) curve in Figure S12 (top). Crucially, the curve lies firmly above the 
diagonal line.  Two points on this curve that correspond to the maximum F1 score and 
Matthews Correlation Coefficient (MCC), are independent metrics of the balance 
between accuracy and precision and are marked on the ROC curve (red and green dots, 
respectively).  Of particular interest is the threshold corresponding to the F1 max (J cutoff 
of 30), which appears to capture almost 70% of the BP interactions, with only a 40% 
false positive rate.  The network of couplings above the F1-max threshold (Figure S12 
bottom left) is still highly coupled with 122 couplings out of a possible 289, of which 18 
are captured in the BP network (Figure S12 bottom right).  None of the analyses 
presented here argue in favor of either methodology. The best strategy would depend on 
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the method that can produce the best models in terms of reproducing response to trained 
perturbations and predicting response to new perturbations, none of which is evaluated 
here.  Instead, we only have evidence that BP and GGMs are non-trivially capturing 
similar couplings between system variables.   
 
 
Figure S12: Comparison of the most likely Gaussian model couplings and those 
from BP. The ROC curve (A) lies firmly above the diagonal line.  The set of GGM edges 
taken from the F1-max cutoff (B) has many agreeing edges with those returned from BP 
(C). 
 
It is important to realize that GGMs, however useful, are not sufficient for our modeling 
needs by themselves.  For instance, they do not infer direction.  Additionally, GGMs have 
no dynamic engine with which to run simulations of the models to predict response to 
perturbation.  Despite these limitations, GGMs remain a well-regarded and 
mathematically grounded analysis of significant correlations. We are currently exploring 
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ways of incorporating this GGM analysis into the BP-based strategy, potentially using 
GGMs to define reasonable initial conditions for all marginal distributions.  
 
Supplementary Text S4: Effects of the discretization assumption (Assumption 1) 
 
The result of Assumption 1 in the main text is that BP can only approximate an otherwise 
continuous distribution (the marginal probability of any single parameter) with a discrete 
distribution.  This begs the question of how to pick the scope (maximum weight 
magnitude) and the resolution or the number of intermediate values (number of bins). In 
the manuscript we state that both scope and resolution were picked based on heuristic 
evidence from extensive numerical studies, from which we conclude that 11 discrete 
values between -1 and 1 are sufficient to guarantee convergence and recover non-trivial 
variance in the resulting distributions, which balance exploration of a large solution space 
against the desire for sufficient constraints on the solution space.  In this brief, 
preliminary study, we wish to share our current progress on investigating this issue more 
quantitatively.  This analysis was done on a single dataset from mcf7 breast cancer cell 
lines. 
 
The choice of discretization affects three main features of the BP algorithm: convergence, 
consistency and sensitivity.  Convergence is the ability of the BP algorithm to terminate 
to a stable set of marginal probability distributions. Consistency is the agreement between 
replicate runs of BP on the same data and depends highly on the initial conditions (initial 
guess distributions), the order of the updates and the discretization. We have recently 
discovered that a large number of replicate runs of BP sometimes converge to a much 
smaller number of unique solutions, each of which is a stable local minima in the error 
landscape. This is a newly discovered and complex issue and is beyond the scope of this 
analysis.   
 
Sensitivity concerns the ability to capture probability mass that is concentrated between 
any two discrete parameter values. Consider the hypothetical example where BP is 
restricted to consider only parameter values -1, 0, and 1 but where the true weight value 
is -0.5.  This means that the update inside BP can only consider all-on (positive or 
negative) or all-off parameters. The worry is that the entire marginal might also converge 
to all-on or all-off distributions, such that one value is given 100% probability and all 
other values have a probability of 0%. Equally problematic would be the result where the 
probability distribution splits the probability evenly across -1 and 0, such that half of the 
samples drawn from this distribution would not have a true interaction and even then 
would be fixed to a value far from its true value.   
 
To investigate this sensitivity, we track the entropy of the set of marginal probability 
distributions resulting from different discretization strategies.  Roughly, the entropy 
quantifies the degree of uncertainty captured in a probability distribution.  Importantly, it 
does not say anything about the accuracy of the resulting distribution, which is a separate 
issue.   Distributions with absolute certainty have zero entropy, while maximum entropy 
describes even distributions where all weight values are considered equally likely.  We 
consider three different scopes with maximum weight magnitudes of 1, 2 and 3. For each 
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scope, we consider 8 different resolutions, where the range is divided into equally spaced 
bins.  We consider a minimum of 3 bins covering one negative, one positive and one 
zero-valued weight.   
 
The metric of interest is the sum of the entropies of all BP-calculated probability 
distributions.  We calculate the entropy for each set of marginal distributions from 100 
independent runs of BP to get a sense of the variability of entropies across replicates. One 
consideration is the choice of normalization, since the maximum entropy (entropy of 
even distributions) increases with the number of bins.  One choice is to normalize the 
entropy by the maximum entropy for that bin number (Figure S13). Yet another choice is 
to collapse a distribution into a ternary distribution of negative, positive and zero values, 
by calculating the aggregate probability mass over all negative, positive and zero values, 
respectively (Figure S14). These collapsed ternary distributions are fundamentally 
different from the BP-calculated distributions over only three values in that prior to 
collapse, the BP considered a larger number of possible values and could capture 
intermediate positive and negative values. 
 
Figure S13: Entropy as a function of the number of bins. Entropy is normalized by the 
ratio of total entropy to maximum possible entropy. This analysis is focused on exploring 
the effects of different discretization strategies (Assumption 1) on the BP inference. 
 
 
In both Figures S13 and S14, discretizing over 3 bins produces distributions with low 
entropies near zero, confirming the suspicion that such discretization tends to yield all-or-
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nothing marginal probability distributions. These distributions are dangerous since they 
likely over constrain the search space. Furthermore, true non-zero values are given zero 
probability and thus would never appear in models drawn from these distributions. In 
short, appropriate uncertainty is not capture in these distributions.   
 
 
Figure S14: Entropy as a function of the number of bins.  This time, entropy is 
calculated on a collapsed distribution over three regions; aggregate probability mass for 
negative values, zero values and positive values. 
 
Both normalization strategies show increase in the entropies with increasing the number 
of bins. Both curves are sub-linear and appear to saturate at increasing bins.  There are 
two major differences in the features of these normalizations.  First, is that the entropies 
over the ternary distributions saturate faster and most of the increase in this entropy 
happens between 3 and 11 bins. Conversely, the entropy increases substantially all the 
way up to 41 bins in Figure S13.  Without supplementing this analysis with comparisons 
of marginal quality (in terms of accuracy or predictive power), it is unclear which 
discretization strategy is optimal and whether there is any useful advantage to higher 
resolutions beyond 11 bins. 
 
 
The second major difference between Figures S13 and S14 are the vertical shifts in the 
curves between different scopes.  This phenomenon in S13 is easily explained by the fact 
that increasing the scope for a constant bin number results in a proportional increase in 
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distance between discrete weight values. Assuming that two distributions have identical 
means and variances, then widening the scope without a changing the number of bins, 
would concentrate the probability mass over fewer bins resulting in a lower entropy. This 
is likely why we see uniform decrease in entropies in Figure S13 for increasing scopes.  
This artifact is not applicable for the entropy calculation in S14. In Figure S14 we notice 
the vertical shift from high entropies with a scope of 1 to lower entropy curves that are 
very similar for scope of 2 and 3.  The reason for this shift is not yet solved. One 
hypothesis is that there is more uncertainty when the scope is insufficiently small.  If the 
scope were too small, then the largest magnitude value is insufficient for some 
parameters although we hope that those values be given a non-zero probability. Because 
of this inefficiency, BP must explore alternative parameters to compensate for the 
unexplained variance between observed and expected.  This hypothesis also explains why 
the entropy curves are similar for both scopes of 2 and 3.  If the true scope were between 
1 and 2, then any scope above 2 would cover superfluous parameter values.  And since 
the entropy in Figure S14 is only a function of the aggregate probabilities of all negative, 
positive and zero-valued weights, then the entropy is agnostic to the distance between 
weight values, unlike the entropies in Figure S13. 
 
These results are inconclusive and communicate only our progress towards achieving an 
objective strategy for picking an optimal scope and discretization that maximizes 
convergence rates and is sufficiently sensitive to balance the desire to explore parameter 
space against the attempt to restrict the parameter space to the most likely parameters. 
 
Supplementary Text S5: The Monte Carlo Algorithm employed in this manuscript. 
 
We compare Belief Propagation (BP) against a standard Monte Carlo (MC) algorithm, as 
MC is ubiquitous and well understood throughout the literature.  MC also has its roots in 
statistical physics.  If MC is run through enough iterations, it is guaranteed to ultimately 
traverse the entire solution space and is in this, respect, a greed search algorithm.  Such 
exhaustive searches are prohibitively long and thus an adequate termination criterion 
determines the run time of the MC.  Marginal probability distributions are drawn from 
MC solutions by summing the frequency each parameter appears and weighting it by its 
likelihood. BP is guaranteed to converge to the exact marginal in tree-like relationships 
(no loops) between variables and constraints. However, since our problem is fully-
connected, each variable is connected to all constraints, BP is not guaranteed to converge 
to the true marginal and is only an approximation.  Since BP is a method to approximate 
the same marginal probabilities, MC is a suitable candidate for comparison. 
 
MC relies on assumptions 1 and 2, as introduced in the main document.  This is 
necessary, since it is imperative to compare both BP and MC such that they are tasked to 
solve the same problem with the same likelihood function over an identically sized search 
space.  On the other hand, neither assumptions 3 nor 4 are not applicable to the MC 
algorithm, as MC is a search over discrete parameter configurations. Therefore, 
comparing BP results against MC results might isolate the effects of assumptions 1 and 2, 
collectively, on the quality.  It should be noted that letting MC run for longer times would 
improve MC performance.  
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We encode a termination criterion that stops when the algorithm has found a strongly 
attracting minimum for a pre-fixed number of iterations.  Our MC algorithm keeps track 
of the top 1,000 configurations it has encountered, as evaluated by the log-likelihood (or 
cost function) in Equation 6b.  MC traverses solution space by drawing each parameter 
from a zero-heavy distribution, where all non-zero weights are given equal probability.  
When the current configuration has lower cost than the previous configuration, it is 
accepted and appended to the list of the top 1000 configurations, while the highest cost 
configuration in the list of the top 1000 is expelled.  In order to prevent the search from 
getting stuck in a weakly attracting local-minimum, we consider accepting higher cost 
configurations with probability: 
 𝑃 𝑘𝑒𝑒𝑝  𝑊𝑛𝑒𝑤 =    𝑒!(!!"#)𝑒!(!!"##$%&) 
The algorithm terminates when the list of the top 1000 configurations does not change 
after 1000 iterations. 
  
 70 
 
Figure S-15: Schematic illustration of interpreting model edges and activity nodes. 
Direct interactions in our models do not necessarily imply direct biological interactions 
(A).  Rather the separation between any two connected nodes is dependent on those 
nodes that are included in the model, which is in turn a function of the availability and 
specificity of assays for various proteins and phospho-proteins.  Consider the linear 
cascade of 5 nodes (A). When intermediate nodes are excluded from the model, for 
whatever reason, the true direct interactions are also excluded. In their stead, the model 
will have interactions between the neighboring nodes.  In that case, the direct model 
interactions do no correspond to direct biological interactions. The use of activity nodes 
may also confuse the interpretation of our model interactions. Activity nodes stand in for 
the activity of a protein (or phosphorylated protein) that is not directly measureable, as 
explained in the Materials and Methods section of the main manuscript.  It is this activity 
that is being targeted by a given drug.  We can assume that the activity is below basal (x 
is negative) when the drug is applied.  However, in those conditions in which the drug is 
not applied we have no data or reasonable assumption with which to approximate the 
activity nodes. Consequently we do not have enough data with which to infer interactions 
into activity nodes.  Activity nodes are therefore restricted to exist as ‘root nodes’ such 
that they have only outgoing edges (B).  We consider the activity nodes to represent the 
effect of ad rug on the rest of the model nodes. 
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Supplementary Text S6: BP Implementation considerations. 
 
The main manuscript covers all of the theoretical considerations of our BP algorithm.  
However, there are a few implementation issues that affect the efficiency of the 
algorithm.  
 
Computational calculation of Equation 14.A for each update requires substantial memory 
and computational power. The algorithm has to keep track of all M x(N -1) factors, and 
then perform M multiplications, (N-1) times in preparation for a single update. We take 
advantage of the multiplicative relationship between a marginal P(wij ) and its factors 
ρµ (wij ) , to reduce the number of computations need to evaluate Pµ (wij ) and eliminate 
precision error associated with many multiplications of small numbers. 
The marginal distribution and the global information are related by a simple division of 
the marginal by the cavity factor (Equations S1A and S1B). In log space, the same 
calculation is just a simple subtraction (Equation S1C). 
Equation S1 
P(wij ) = e−λδ (wij ) ρν (wij )
ν
M
∏
Pµ (wij ) =
P(wij )
ρµ (wij )
lnPµ (wij ) = lnP(wij )− lnρµ (wik )
= −λδ(wij )+ lnρν (wij )− lnρµ (wik )
ν
M
∑
 
 
The calculation in equation  S1C is a fast calculation and involves only an inverse log 
operation, one subtraction and the cost of doing the normalization (K additions and K 
division operations).  The calculation needs only to keep track of all factors and the sum 
of the natural logarithms of the factors across all M conditions, stored in an array Ψ . 
 
Equation S2 
Ψ( j) = ln ρν (wij )( )
ν
M
∑ −λδ(wij )
Pµ (wij ) =
1
Z e
Ψ ( j )−ln(ρµ (wik ))( )
 
 
An additional advantage for performing the calculation in log space is that the operation 
does not risk precision errors from the multiplication of many small numbers.  The 
calculation is a subtraction of negative numbers followed by a natural antilogarithm 
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calculation, neither of which risk precision error. In non log space, the calculation 
requires M multiplications of probability distributions, which contain some very small 
numbers.  In fact, an earlier implementation of the BP algorithm experienced detrimental 
errors for even small M.  This error cascaded and produced meaningless results.  The log 
space calculation is robust up to about at least M=1,000, above which has not been tested. 
 
Analytical approximation of the local factor update 
The integral in Equation 14B is not solvable analytically due to the nonlinearity 
introduced from the sigmoid function φ(z) . One can solve the integral numerically with a 
method such as trapezoidal integration.  However, since Equation 14B has to be 
calculated NxM times per iteration over many iterations, numerical solutions of this kind 
dramatically slow down the computational time to convergence.  To alleviate the cost of 
this calculation, we use a simple algebraic rearrangement as shown in Equation S4B to 
make the fitness term Fµ (skµ )  linear with the integration variable skµ .  
 
The goal is to rewrite the error inside the sum of squares term to be linear in skµ . The 
fitness is maximum when the cost is zero and therefore xi*µ = xiµ , which in turns means 
that xi*µ = φ(skµ +wikxk*µ ) .  Inverting the nonlinear function on both sides of the equation 
(Equation S3A) and yields an approximation of the fitness that is linear with skµ . 
 
Equation S3 
φ −1(xi*µ )−wikxk*µ = skµ
Fµ (skµ ) = e([φ
−1(xi*µ )−wikxk*µ ]−skµ )2  
 
Equation S4 is the analytical solution to the integral in Equation S3B. 
 
Equation S4 
ρµ (wik ) = e
−βwikxk*µ+[−φ−1(xi*µ )−skµ ]
2βσ 2+1  
 
 
The Algorithm 
See Figure-S16 for an algorithm flow-chart. 
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Figure S-16: Algorithm flow chart. 
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Supplementary Table S1: Quantitative details and biological significance of inferred 
interactions 
 
Modeled 
Interaction 
Confirm
ed 
<Wij>  Notes 
 
Y 1.00 PKC mediates the phosphorylation of 
STAT3 at Y727 following STAT3 
phosphorylation at Y705 and dimerization. 
Thus, this is a potential logical interaction. 
 
N 0.97 A predicted interaction. Possible negative 
feedback acting from PI3K/AKT pathway to 
upstream SRC. 
 
Y 0.94 Indirect/logical interaction. RAF/MEK/ERK 
signaling induces Cyclin D1 expression and 
regulates the transition from G1 to S phase. 
 
N 0.92 P27/Kip1 is a tumor suppressor that inhibits 
cyclin D1. BIM is a proapoptotic protein. 
The response profiles of the two proteins are 
highly correlated. The inferred interaction 
reflects this correlation. Observed edge may 
be due to a logical interaction. Both proteins 
are co-regulated by FoxO transcription factor 
in response to IL-2. 
 
Y 0.89 The inferred edge between CyclinD1 and c-
Myc is bidirectional. c-Myc transcription 
factor regulates expression of a large 
spectrum of oncogenic proteins including 
cyclins. The response profiles of CyclinD1 
and c-Myc are highly correlated. However, 
the inverse regulation is not reported in 
literature.  
 
Y 0.87 PLK1 and CyclinB1 interaction is critical for 
G2/M transition in cell cycle. This is 
validated as a direct interaction. 
 
Y 0.86 Element of PI3K/AKT pathway. aAKT is an 
activity node, which spesifically corresponds 
to localization of AKT to membrane through 
PIP3 binding in our context.After membrane 
recruiutment, phosphorylation at S473 
activates AKT. 
 
Y -0.85 BIM and MAPK bidirectional interaction is 
inferred in network models. Multiple studies 
suggest that proapoptotic activity of  BIM is 
regulated by MAPK through 
phosphorylation at multiple sites. 
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Y 0.69 Well established logical interaction. PI3K 
facilitates the membrane localization and 
phosphorylation of through PIP3 formation. 
Once localized, AKT is phosphorylated at 
T308 by PI3K dependent kinase 1 (PDK1). 
This phosphorylation is followed by a 
second phosphorylation at S473 by mTOR-
rictor complex.  
 
Y 0.68 Part of PI3K/AKT pathway.  amTOR is an 
activity node. Phosphorylation at S240 
activates S6. This is an indirect interaction 
that takes place through p70S6K (not 
included in the model.).  S56 activation 
triggers Protein translation. 
 
Y -0.66 MAPK phosphorylates BIM on multiple 
Serine sites leading to degradation of BIM. 
 
Y 0.62 Phosphorylation of tumor suppressor protein 
Rb at S807 by CDK4/6 leads to its inhibition 
of Rb and G1/S transition. CDK4/6 
activation by Cyclin D1 has a major role in 
inducing Rb phosphorylation. 
 
N 0.59 In canonical RAF/MEK/ERK pathway, an 
indirect, logical interaction could be defined 
from MEK to Rb deactivation. However, this 
interaction has an opposite direction. Few 
studies point an indirect, bidirectional 
genetic interaction with Rb and N-RAS, 
which is upstream of MEK. The observed 
edge could be a false positive due to the high 
experimental  correlation observed in 
response profiles of two proteins or may 
reflect a highly complicated, indirect 
interaction between MEK and Rb. 
 
Y 0.57 PKC regulates STAT3 phosphorylation (see 
above) and PKC inhibition leads to cell 
death. The inferred edge reflects the 
influence of PKC inhibition on cell viability 
through STAT3 activity. 
 
N 0.56 The reverse interaction is reported as an 
indirect event. This is a novel prediction and 
requires experimental validation. 
 
Y 0.54 PLK1/CyclinB interactions function to 
activate CDK1 activation, which in turn 
phosphorylates and activates tumor 
suppressor Rb. An inverse interaction is 
reported such that Rb activation leads to the 
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suppression of PLK1 expression. 
 
N 0.54 This is a possible negative feedback loop 
acting on Src from Cyclin D1. Src is 
deactivated when phosphorylated at Y527. 
Src is upstream of multiple pathways, whose 
activation lead to increase in Cyclin D1 
expression. 
 
Y 0.52 CyclinB1-CDK1 and PLK1 activity induce 
G2/M transition in cell cycle. PLK1 is an 
important target for anticancer drugs. 
CyclinB-CDK1 complex and PLK1 regulate 
the activity of each other. However, the 
activation of PLK1 by CyclinB1 is most 
probably an indirect process in mammals and 
the precise functional relationship between 
them is highly dependent on biological 
context. Note that in X. leavis CDK1 directly 
phosphorylates PLK1 At S340 (not 
conserved in mammals) and induces its 
activation. 
 
Y 0.50 Part of canonical BRAF/MEK/ERK 
pathway. 
 
 
